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ABSTRACT 
Background: The evolution of antibiotic resistance is a global public health crisis 
building over decades. In this build-up antibiotic use has been the main driver for 
antibiotic resistance. To develop context-specific interventions, effective surveillance 
of antibiotic use and resistance are needed in counties like India, which have witnessed 
a rapid rise in resistance recently and where the need for effective antibiotics is high. 
Aim: The main aim of this thesis is to increase the knowledge regarding antibiotic 
prescribing patterns and prevalence of resistance in an Indian setting, so as to identify 
targets for interventions aimed to improve clinical practice for common infections. 
Methods: This thesis includes five cross-sectional studies. Paper I and paper II 
describes the patterns of antibiotic prescribing for outpatients with suspected infectious 
aetiology and among admitted patients, respectively. The defined daily doses (DDDs) 
were calculated per 1000 patients per diagnosis considered in paper I. Focus of 
infection specific DDDs were calculated per 100 patient days in paper II. In paper III, 
prescriptions for children with diarrhoea were analysed for adherence to treatment 
guidelines and factors associated with adherence were explored. In paper IV healthy 
children were screened for nasal carriage of S. aureus to identify factors associated 
with nasal carriage and to describe the resistance patterns. Paper V describes the 
antibiotic susceptibility pattern of pathogens isolated from patients with suspected 
infections. Antibiotic susceptibility testing was performed by Kirby-Bauer disk-
diffusion method. All the studies were done using structured, pilot tested 
questionnaires.  
Results: Overall antibiotic prescribing was 66.3%, 3732 out of 5623 outpatients (Paper 
I) and 92%, 5531 out of 6026 admitted patients (Paper II). Quinolones were the most 
frequently prescribed antibiotic group among outpatients and third generation 
cephalosporins among the admitted patients (Paper I and II). For diarrhoea in children 
only 6 out of 843 prescriptions adhered completely to treatment guidelines. Oral 
rehydration solution (ORS) was prescribed for 58%, ORS with zinc for 22% and 
antibiotics for 71% of the cases (Paper III). The prevalence of nasal carriage of S. 
aureus was 98 out of 1562 i.e. 6.3% (95% confidence interval [CI] 5.1-7.5).  Of these, 
16.3% were methicillin-resistant S. aureus (MRSA). Overcrowding was associated 
with nasal carriage of S. aureus (Paper IV). Among pathogens (n=716) isolated form 
admitted patients (n=2568), Gram-negative pathogens predominated (62%). Extended-
spectrum β-lactamase (ESBL) production in E. coli isolates (n=149) was 69% (95% CI 
61.6–76.6) and in K. pneumoniae isolates (n=107), 41% (95% CI 31.6–50.5). MRSA 
constituted 30% of all S. aureus isolates (n=221).  
Conclusions: The targets identified for interventions were: high antibiotic prescribing 
rates for diarrhoea (Paper I, II and III) and upper respiratory tract infection (Paper I). 
Other targets include, longer than recommended duration of prophylaxis (86% of 1846 
patients) and lack of distinction between prophylaxis and therapy among surgical 
patients, irrational antibiotic prescribing in gastroenteritis, overuse of quinolones and 
lack of use of penicillin in pneumonia, overuse of quinolones and lack of use of 
doxycycline and macrolides in genital infections, and overreliance on antibiotics in 
treating skin and soft tissue infections (Paper II). The high rate of antibiotic prescribing 
among admitted patients together with the high rates of ESBL producing pathogens 
shows urgent need to curb antibiotic use when there is no indication for it (Paper V). 
Key words: antibiotic prescribing, antibiotic resistance, patients, surveillance, defined 
daily dose, foci of infection, adherence, diarrhoea treatment guidelines, nasal carriage, 
S. aureus, extended-spectrum β-lactamase, pathogens, India.  
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DEFINITIONS 
 
 
1. Acute watery diarrhoea: is defined as “three or more watery stools in a 24-hour 
period without blood, a loose stool being one that would take the shape of the 
container.” (WHO 1996) 
2. Antimicrobials: Class of substances that can destroy or inhibit the growth of 
pathogenic groups of microorganisms, including bacteria, viruses, parasites, and 
fungi. 
3. Antibiotic: Class of substances that can kill or inhibit the growth of some 
groups of microorganisms. In this thesis antibiotics refer to chemicals active 
against bacteria. Originally antibiotics were derived from natural sources (e.g., 
penicillin from molds), but many currently used antibiotics are semi-synthetic 
and modified with additions of man-made chemical components. 
4. Antibiotic resistance: there is no consensus definition of bacterial resistance to 
antibiotics. The European Society of Clinical Microbiology and Infectious 
Disease Committee for Antibiotic Susceptibility Testing (EUCAST) defines 
antibiotic resistance as “microbiological resistant bacteria that possess any 
resistance mechanism demonstrated either phenotypically or genotypically”. In 
this thesis phenotypic demonstration of resistance by disk diffusion test is used. 
('EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to 
methods for the determination of susceptibility of bacteria to antimicrobial 
agents'  2000).   
5. Defined Daily Dose (DDD): as defined by the World Health Organization 
Collaborating Centre for Drug Statistics Methodology, Oslo- The DDD is the 
assumed average maintenance dose per day for a drug used for its main 
indication in adults (World Health Organization Collaborating Centre for Drug 
Statistics Methodology 2010) 
6. Empirical therapy: Is a medical term referring to the initiation of treatment prior 
to determination of a firm diagnosis. 
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PREFACE 
“You can’t cross the sea merely by standing and staring at the water” 
 
My life has always been inspired by these words of Rabindranath Tagore. I therefore 
decided to leave my state of Madhya Pradesh (MP) in pursuit of better education and 
did my under graduation from TN Medical College & BYL Nair Municipal Hospital, 
Mumbai. Paediatrics fascinated me from day one of my Paediatrics ward posting in 
second year of MBBS. But before I could start my post-graduation in Paediatrics we 
were required to work as medical officer at a rural peripheral health centre (PHC). I 
went to a tribal PHC in Dhule, Maharashtra in the year 1998-99. This was my first 
brush with public health. 
 
I always wanted to work in my hometown and so when I completed my post-
graduation I moved back to Ujjain, MP in 2004. I started working at Department of 
Paediatrics, RD Gardi Medical College then as a senior resident and continue to work, 
now as associate professor. I realized that despite having adequate clinical competency 
I lacked the necessary research competencies. But, having inherited some “research 
genes” from my father, an accomplished entomologist, I volunteered to work with Prof. 
Cecilia when we first met in 2004. We did our first pilot study on antibiotic use in 
2005, and that was just the beginning. 
   
A carrier in research is difficult for clinicians like me in India mainly because the lure 
for private clinical practice is usually too much to resist. In spite of that, I took the 
plunge in 2007, registered as a PhD student in 2009, and never looked back since. The 
PhD journey has given me opportunities, which are hard to find in India. I have tried to 
utilize them as much as possible. Now, a public health prospective enriches my 
experience with every individual patient I look after and vice-versa. I think the PhD 
training has transformed a Paediatrician into “a pharmacoepidemiologist, an infection- 
control physician and a budding microbiologist”. But the skill I cherish the most is the 
working knowledge of “Stata”.  
 
The implications of my research and also the dilemma I faced during this PhD work is 
reflected in the photograph on the cover page of this thesis. It is about the conversation 
between Lord Krishna and the Pandava prince, Arjun that took place in middle of a 
battlefield before the start of the war described in the epic Mahabharatha. With armies 
standing on both sides ready for battle, Arjun a great archer refused to fight due to 
moral dilemma of fighting his own cousins. The context of the Gita is Lord Krishna’s 
reply to Arjun. In many ways, this reflects my own dilemma: how to criticise my own 
colleagues when I am one of them. But, I think that I have been quite critical of my 
colleagues.  According to me, the painting is also a reflection of the current scenario in 
India with respect to antibiotic resistance, giving us a glimpse of the havoc awaiting us 
………………………..“the lull before the storm”! 
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1 BACKGROUND 
1.1 ANTIBIOTIC RESISTANCE: A GLOBAL PUBLIC HEALTH CHALLENGE  
Antibiotics are considered an important element in the armamentarium of modern 
medicine. When antibiotics are used to treat diseases caused by bacteria, most of the 
bacteria are killed but a few surviving bacteria can respond by becoming resistant to the 
antibiotic used. This response is a natural adaptation for survival by the bacteria. Thus, the 
effective lifespan of antibiotics is limited. Many patients throughout the world suffer harm 
due to antibiotic resistance because bacterial infections are not susceptible any more to 
antibiotics used to treat them (WHO 2012a).  
 
When Fleming discovered penicillin he had observed that some bacteria are inherently 
resistant and some sensitive (Fleming 1929). He forewarned the effects of “indiscriminate 
use” in his Nobel lecture where he noted that initially sensitive bacteria could become 
resistant, especially if exposed to low doses of antibiotics ('Sir Alexander Fleming - Nobel 
Lecture') but the scientific community continued to ignore this advice. By the 1980s, it was 
believed that man had already learnt all there is to know about antibiotic resistant bacteria, 
which translated to a reduction in funding for research in this area. The field of antibiotic 
use and bacterial resistance was considered “old fashioned”, thus drastically reducing the 
number of scientists working in the field. The last two decades however, have seen a 
resurgence of interest in the field of antibiotic use and resistance and can be described as 
the ‘dawning’ of awareness of the antimicrobial resistance problem especially in resource-
rich countries. The insurance companies in the United States in particular recognized this 
problem due to the increasing costs associated with treating resistant organisms (Alvan et 
al. 2011, Barbosa and Levy 2000, Boucher et al. 2009, Cars et al. 2008). Today the topic of 
antibiotic resistance is in the forefront, because of the increasing realisation that we lack 
even the basic knowledge about the mechanisms of resistance. Extensive work has been 
done and is going on in the field but still many questions, particularly related to horizontal 
gene transfer among environmental and pathogenic bacteria, remain unanswered (Alvan et 
al. 2011, Barbosa and Levy 2000, Boucher et al. 2009, Cars et al. 2008, French 2010, 
Grundmann et al. 2011, Johnsen et al. 2009). There is insufficient information about the 
conditions and factors that lead to the mobilization, selection and movement of resistant 
bacteria or resistant genes into and between animal and human populations (Alvan et al. 
2011). It is important to answer these questions because horizontal gene transfer maintains 
the acquired gene pool of resistance in a community. 
 
 
1.1.1 A problem building up over decades 
Very few countries had the foresight to implement preventive programmes and policies to 
reduce inappropriate antibiotic use and improve hygiene (Grundmann et al. 2011). Even in 
countries with preventive programmes and policies in place antibiotic resistant bacteria can 
be imported and persist in the environment, especially in farm animals (Grundmann et al. 
2011, Johnsen et al. 2009). Antibiotic resistance is thus a global public health challenge of 
paramount importance (Alvan et al. 2011, Cars et al. 2008, French 2010, WHO 2012a). 
The evolution of antibiotic resistance threatens the success of medical interventions at all 
levels of health-care and in countries at all economic levels (Alvan et al. 2011, Cars et al. 
2008, French 2010, Shanmugam 2011, WHO 2012a). This evolution has been building up 
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over decades, so today many common infections, which were easily treatable, are 
becoming difficult to treat (WHO 2012a).  
 
1.1.2 Consequences of antibiotic resistance 
Estimates from Europe suggest that excess deaths due to resistant bacterial hospital 
associated infections exceed 25,000 annually (ECDC 2010). The number of extra hospital 
days was estimated to be 2.5 million (ECDC 2010). The expenditure associated with these 
infections in terms of extra hospital costs and productivity losses exceed €1.5 billion each 
year (ECDC 2010). Similar estimates from the low-and middle-income countries are found 
wanting, primarily due to lack of surveillance systems to gather such information. 
 
In many healthcare settings, especially in the low and middle-income settings, antibiotics 
are prescribed empirically. Empiric therapy is refers to the initiation of treatment prior to 
conformation of a firm diagnosis. At individual level therefore, antibiotic resistance can 
lead to treatment failure due to wrong choice of empirical antibiotics. Failure of initial 
antibiotic therapy leads the treating physician to prescribe alternative antibiotics, often 
labelled as “second-line” or “third-line” antibiotics. These antibiotics differ from hospital to 
hospital and from one region of the world to another. But, generally failure of initial 
antibiotic therapy leads to prescribing of more costly and many times more toxic 
alternatives (Boucher et al. 2009). In hospitalised patients antibiotic resistance leads to 
prolonged hospitalisation and is associated with increased risk of mortality and morbidity 
in the infected patient (Kollef et al. 1999). In case of sepsis the increased mortality is not 
always related to increased virulence of the resistant bacteria but often due to inappropriate 
initial choice of antibiotics for initiating treatment of clinical sepsis. An inappropriate initial 
choice leaves the patient essentially unprotected for a period of time, which is critical for 
survival (Kollef et al. 1999, Ibrahim et al. 2000). The impact of antibiotic resistance, at the 
hospital level includes, increased risk of cross-infection of resistant health care associated 
infections (HAI). A high HAI rate is a “bad reputation” for the concerned hospital (Goff 
2011). An increased actual or perceived risk of HAI by the physicians in a health-care 
setting leads to a shift in practice to more broad-spectrum empiric therapy leading to 
“empiric spiralism” (Kim and Gallis 1989) i.e. a perceived need to prescribe more broad-
spectrum antibiotic cover to address the concern about increasing prevalence of resistant 
bacteria. At the societal level, there is increased burden of care and increased physical and 
psychological costs of leave-of-absence (Sarkar and Gould 2006, Goff 2011). The 
consequence of antibiotic resistance is therefore an increased cost of care for the individual, 
hospital and society (Pile 2011). The increased cost of care is usually borne by the patient 
as out-of-pocket expenditure in countries like India (De Costa et al. 2009).  
 
1.1.3 Recent global concerns regarding antibiotic resistance 
The global concerns on antibiotic use and resistance are reflected by the call for concerted 
action from all quarters and increased availability of reports dealing with this matter 
(Ferech et al. 2006, Goossens et al. 2005, Coenen et al. 2009, Cars et al. 2008). During the 
last decade, antimicrobial resistance has moved steadily to a more and more prominent 
position in the global public health agenda (WHO 2012a). The World Health Organization 
(WHO) in the year 2011 celebrated the World Health Day on the 7th April, with the slogan 
“Antimicrobial resistance: no action today, no cure tomorrow” (WHO 2011).  A six-point 
policy package was introduced and countries were called upon to (1) commit to a 
comprehensive, financed national plan with accountability and civil society engagement, 
(2) strengthen surveillance and laboratory capacity, (3) ensure uninterrupted access to 
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essential medicines of assured quality, (4) regulate and promote rational use of medicines 
in animal husbandry and to ensure proper patient care, (5) enhance infection prevention 
and control, and (6) foster innovations and research and development of new tools (WHO 
2011). 
 
Another recent concern is the apparent shift of resistance burden from Gram-positive 
pathogens to Gram-negative pathogens. This shift is of a concern because there is an empty 
pipeline of new or effective treatment options for the emerging Gram-negative infections 
(Brusselaers et al. 2011, WHO 2012a). The recent spread of Enterobacteriaceae with 
resistance to carbapenem conferred by New Delhi metallo-β-lactamase 1 (NDM-1) 
received extensive media coverage for two reasons: the bacteria carrying the bla(NDM-1) 
gene are resistant to all antibiotics except tigecycline and colistin, and they are rapidly 
transmitted across national borders (Kumarasamy et al. 2010).  
 
Transfer of resistant genes or bacteria from the environment or food to humans is also of 
major concern (WHO 2012a). Antibiotic use in animals can account for up-to 50% of the 
total antibiotic production in the world (WHO 2012a). Antibiotics in animals can be used 
for a wide variety of non-therapeutic purposes that include growth promotion (Marshall 
and Levy 2011). Antibiotic resistance has been shown in the gut bacteria of the animals fed 
antibiotics and also food products made from animals that have received antibiotics. This 
resistance can spread to other animals and humans directly by contact and indirectly via the 
food chain, water, air, and manured and sludge-fertilized soils (Marshall and Levy 2011). 
The role of presence of antibiotics and antibiotic resistance genes in the hospital 
wastewater is also of major concern for spread of bacteria in the environment (Diwan et al. 
2010, Diwan et al. 2012). 
 
1.2 MEASURING ANTIBIOTIC USE AND RESISTANCE 
1.2.1 Measuring antibiotic use  
The antibiotic use data can be gathered at various healthcare levels or in the community, 
using different sources and methods (WHO 2012a). For health care, data could be gathered 
at primary care or hospital level and results presented as total use for the hospital using the 
purchased, prescribed, dispensed or administered data on antibiotics. Antibiotic use data 
could also be gathered at ward level or for outpatient clinics and admitted patients 
separately. Disease or symptom specific data could be more granular in identifying 
rationale antibiotic use, analysing adherence or compliance with standard treatment 
guidelines and to inform and evaluate resistance containment interventions. Point 
prevalence survey method as described by the European Surveillance of Antimicrobial 
Consumption (ESAC) is suitable for adapting to different health-care facilities (Zarb and 
Goossens 2011).  
 
The various methods that can be used for antibiotic surveillance are: review of 
prescriptions, review of pharmacy sale or dispensing data, and drug purchase or 
procurement data (WHO 2012a). In places where the health system is weak, and there is 
no previously established surveillance system, WHO recommends measuring the 
following parameters: percentage of patients receiving antibiotics, pneumonia cases 
treated with recommended antibiotics, cases of upper respiratory tract infections 
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receiving antibiotics, and percentage of patients receiving antibiotics without 
prescriptions (WHO 2012a).  
 
The antibiotic use can be reported as total use in grams, number of antibiotics 
constituting the 90% of the total drug utilised (DU90), financial cost for the patient or 
health care facility or total days of therapy, or by using prescribing indicators (Berrington 
2010). The standardised measure of reporting antibiotic use information is by using the 
WHO Collaborating Centre for Drug Statistics Methodology, Anatomical Therapeutic 
Chemical (ATC) classification with Defined Daily Dose (DDD). By definition, the DDD 
is the assumed average maintenance dose per day for a drug used for its main indication 
in adults (WHO Collaborating Centre for Drug Statistics Methodology 2010).  
 
The DDD is a unit of measurement and does not necessarily reflect the recommended or 
prescribed daily dose (Muller et al. 2006).  The DDD reflects the global dosage 
irrespective of individual and population level genetic variations of drug metabolism. The 
DDD provides a fixed unit of measurement independent of drug cost, package size, and 
patient-specific dose ordered. To estimate antibiotic use, the total number of grams of 
each antibiotic used (purchased, dispensed, or administered) are summed during the 
period of interest and divided by the WHO-assigned DDD (WHO Collaborating Centre 
for Drug Statistics Methodology 2010). Expressing antibiotic use by DDDs, for example 
using the DDD per 1000 patient days, allows the researcher to compare the antibiotic use 
of one hospital with other hospitals’, regardless of differences in formulary composition 
and antibiotic potency. The main advantage of the DDD methodology is that a researcher 
is able to assess trends in drug consumption and also to perform comparisons between 
population groups (WHO Collaborating Centre for Drug Statistics Methodology 2010). 
The other advantages are, the DDD methodology has a direct link to a widely accepted 
and used therapeutic classification system i.e. ATC/DDD classification system and the 
hierarchical structure of the ATC/DDD system that enables the aggregation of data at 
various healthcare levels. The WHO ATC/DDD system is also freely available. The ATC 
codes are alphanumerical and categorical and are thus easy to use. The main 
disadvantages are that the methodology is not suitable for children and patients with 
impared renal function (Shetka et al. 2005). Also, in computation the alphanumerical 
nature of ATC codes is sometimes a complication.  
 
1.2.2 Relationship between antibiotic use and resistance 
Antibiotics have unfortunately been used excessively and inappropriately since the time of 
their discovery. The extent of antibiotic use is linked to resistance at an ecological level 
(Goossens et al. 2005) and more recently links between antibiotic prescribing and 
resistance at individual patient level have been shown (Costelloe et al. 2010). While 
antibiotics are the central element in selecting resistant bacteria they are not the only 
driving force for persistence of resistance (Barbosa and Levy 2000). Once bacteria acquire 
the elements responsible for resistance and stabilise them, resistance can be then 
transmitted horizontally within and between species (Blake et al. 2003). This makes the 
reversal of resistance very difficult to achieve (Johnsen et al. 2009). The persistence of 
glycopeptide-resistant enterococci in Norwegian and Danish poultry farms 12 years after 
the ban of the animal growth promoter avoparcin is an example (Johnsen et al. 2009). Thus, 
the need for surveillance of antibiotic prescribing to monitor and identify areas for 
improvement cannot be overemphasised.  
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1.2.3 Surveillance networks of antibiotic use and resistance at national, regional 
and global level 
Surveillance involves systematic collection and analysis of health-related data to inform the 
health-care providers, administration and policy makers. An effective surveillance of 
antibiotic use should describe the pattern of antibiotic prescribing and “how” they are used, 
both by the patients and prescribers. The goal of antibiotic use surveillance is to provide the 
information, insights and tools needed to guide policy at local, national and global level 
(WHO 2012a). 
 
At the national level Sweden is one of the most active and successful countries in the fight 
against antimicrobial resistance (Molstad et al. 2008). In Sweden, Strama (the Swedish 
Strategic Programme against Antibiotic Resistance) works for effective use of antibiotics. 
Other networks include, the Norwegian Surveillance for Antibiotic Drug Resistance 
(NORM) (Simonsen 2009), the Danish Integrated Antimicrobial Resistance Monitoring 
and Research Programme (DANMAP) (Bager 2000), the Dutch Working Party on 
Antibiotic Policy (Dutch acronym is SWAB) (Verbrugh 2003), Surveillance of Antibiotic 
Use and Resistance in Intensive Care (SARI) or Medical Antibiotic Use Surveillance and 
Evaluation (MABUSE) in Germany (de With et al. 2004), European Surveillance of 
Antimicrobial Consumption (ECDC, 2010) in Europe (Ansari et al. 2009, Zarb and 
Goossens 2011) and Intensive Care Antimicrobial Resistance Epidemiology (ICARE) in 
the United States (Fridkin et al. 1999). 
 
At the European level the surveillance of antimicrobial resistance was conducted 
previously by the European Antimicrobial Resistance Surveillance System (EARSS), and 
is currently done by the European Antimicrobial Resistance Surveillance Network (EARS-
Net). The network has played an important role to provide good quality data. The 
dissemination of EARS-Net data has increased the awareness of the problem of 
antimicrobial resistance not only in the scientific community but also at the public and the 
political level (ECDC 2010). The 2009 situation analysis report by EARS-Net contains 
data from 28 countries and analyses trends of resistance in many pathogenic bacteria 
(ECDC 2010). Data from Europe confirm a consistent rise in multidrug resistance and 
reveal a steady and significant decline of antimicrobial susceptibility in Escherichia coli. 
On the other hand a steady fall in the hospital prevalence of methicillin resistant 
Staphylococcus aureus (MRSA) has been reported (ECDC 2010). This fall has been 
achieved by active surveillance of carriers and patients in the hospitals and massive hand 
hygiene campaigns.  
 
1.2.4 Need for antibiotic resistance surveillance systems in low and middle-
income countries 
Surveillance of antibiotic resistance is one of the most important components of an 
antibiotic stewardship programme. Antibiotic stewardship is commonly described as a 
programme that provides guidance for selection, dosing, route of administration and 
duration of antibiotic therapy and involves pharmacists, physicians and other healthcare 
providers (Griffith et al. 2012). Antibiotic stewardship is an obligation in European Union 
states and the United Kingdom but is a relatively new concept for Indian hospitals (Griffith 
et al. 2012).  
 
  6 
WHO recognises laboratory-based surveillance of antibiotic resistance as a “fundamental 
priority” for the development of strategies to contain antibiotic resistance and to assess the 
impact of interventions especially in low and middle-income countries (WHO 2011). 
Action has been taken in response to the mounting crisis of antibiotic resistance, but most 
of the efforts have remained confined to resource-rich countries. Many of the existing 
surveillance networks continue to provide useful information (Gagliotti et al. 2011). There 
is however, no formal framework for collaboration among surveillance programmes 
worldwide. This lack of a global framework for collaborative surveillance of antibiotic 
resistance hinders rational discussions on antibiotic resistance patterns and also limits 
systematic comparison and evaluation of various intervention programmes (Grundmann et 
al. 2011). A standardized system for reporting antibiotic resistance needs to be 
established; such a system should rely on both public and private sector laboratories. In 
addition Health and Demographic Surveillance Sites (HDSS) have been suggested to 
obtain information from communities in resource limited settings at household level 
(Grundmann et al. 2011).  
 
 
1.3 HEALTH SYSTEM IN INDIA  
 
 
 
Figure 1.1 The map of India, Madhya Pradesh and Ujjain district 
 
  7 
1.3.1 Public health care in India 
India has 28 states and 7 union territories. States have their own elected governments. India 
has adopted a universal health care system, which is run by the states and union territories 
of India (WHO SEARO 2012). 
 
Rural health services 
India’s primary health care system is based on the primary health center (PHC) and its sub 
centers. Each PHC (manned by a physician and health workers and auxiliary nurse 
midwifes) caters to a population of about 30,000 in the plain areas and for a population of 
20,000 in hilly, tribal and backward areas. Each sub-center provides health care to every 
5000 population in general and for every 3000 in hilly, tribal and backward areas (WHO 
SEARO 2012).  
 
Urban health services 
Most Indian urban areas have secondary and tertiary facilities provided by the government. 
Most of the health care facilities in the government hospitals are either free or highly 
subsidized (WHO SEARO 2012). 
  
1.3.2 Inadequacies of public health services in India 
The performance of the primary public health care in India has been poor. Main reasons 
for poor performance have been pointed out in a world bank report (Radwan, 2005) and 
include: lack of flexibility of public-health structure and administration- resulting in 
ineffective response to the needs of a specific geographical area, lack of accountability-
resulting in absentee doctors and staff, limited staff salaries, informal payments to obtain 
admission to a hospital, to obtain a bed or to obtain or deliver a drug, inability to fill 
vacancies, lack of public health management capacity among administrators or doctors, 
political interference with allocation of resources, poor infrastructure of the health centers 
and the hospitals and little or no community participation.  
       
1.3.3 Private health care in India 
India has one of the most highly privatized health care systems in the world in terms of 
finance and delivery (Sengupta and Nundy 2005). In the year 2005 it was estimated that 
private health care facilities accounted for 82% of outpatient visits, 58% of inpatient 
expenditure, and 40% of births in institutions (Sengupta and Nundy 2005). India ranks 
among the top 20 of the world's countries in its private spending, at 4.2% of GDP (GOI 
2002). According to World Bank estimates in year 2008, 74.3% of the health care 
expenditure was out-of-pocket. As a result, more than 40% of all patients admitted to 
hospital have to borrow money or sell assets to cover expenses, and 25% of farmers are 
driven below the poverty line by the costs of their medical care (GOI 2002).  
 
1.3.4 Other systems of medicine 
Many people in India seek health-care from Ayurveda, Yoga & Naturopathy, Unani, 
Siddha and Homoeopathy (AYUSH) systems of medicine 
(http://www.indianmedicine.nic.in/). These systems run parallel to the allopathic system of 
medicine.  
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1.3.5 Demographic characteristics of India, Madhya Pradesh and Ujjain 
Madhya Pradesh, in its present form, came into existence on November 1, 2000 following 
its bifurcation to create a new state of Chhattisgarh ('Department of Tourism, Government 
of Madhya Pradesh' 2012).  The state is marked with a complex social structure, a 
predominantly agrarian economy. As pointed out in the Table 1.1 below, Madhya Pradesh 
is one of the worst performing states in terms of health indicators in India. 
 
Table 1.1 Comparison of selected demographic indicators for India, Madhya Pradesh and 
Ujjain  
Indicator India Madhya Pradesh Ujjain 
a Population 1.21 billion (more 
than 1/6th of the 
world  population) b 
6% of population of 
India, 72.6 million 
(almost equal to 
population of 
Germany) b 
1.98 million 
c Sex ratio (total) 940 930 954 
c Crude birth rate 20.97 25 24.4 
c Crude death rate 7.48 deaths/1000 
mid-year 
population 
8 deaths/1000 mid-
year population 
6.4 deaths/1000 
mid-year 
population 
c Life expectancy 
(at birth) 
65 58 (lowest in India)  
c Infant mortality 
rate/1000 live births 
49.14 67 (highest in India) 59 
d Maternal mortality 
ratio 
230 (150-350) 310 268 
a Population 
density/km 
384 236 264 
a Literacy rate 
Male 
Female 
 
82.14 
65.46 
 
80.53 
60.20 
 
73.5 
61.2 
a http://censusindia.gov.in/2011-prov-results (provisional results of Census of India 2011) 
b State of World Population, 2010 
c Figures are estimates from Annual Health Survey 2010-11  
d Data refers to estimates done in 2008. Figures in bracket for India are interagency 
estimates as reported by WHO (http://apps.who.int/nha/database/StandardReport) 
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1.4 THE PROBLEM OF ANTIMICROBIAL RESISTANCE IN INDIA 
Rapid evolution of bacterial resistance in India (Kumarasamy et al. 2010) might be the 
result of a complex interaction of several factors. These include: higher burden of 
infectious disease, treatment uncertainty, lack of treatment guidelines, inadequate access to 
standard laboratory facilities, self medication, prescription based on availability, 
government support to pharmaceutical industries, market forces, qualification of the 
prescriber, lax law enforcement, fragmented public health system, poor population-wide 
health coverage, inadequate adherence to universal hygiene and infection control measures, 
and low population-wide education level (Kamat and Nichter 1998, Lakshmi 2008, Sahoo 
et al. 2010, Shanmugam 2011, Varghese et al. 2010). 
 
In this thesis I will mainly discuss antibiotic prescribing with respect to clinical practice. 
The following are examples of the pressures and constraints under which physicians 
prescribe drugs:  
• Prescribing with good intention: Physicians are most often motivated to give 
the best possible treatment often disregarding cost or spectrum of activity of 
the chosen antibiotic (Fishman and Polk 2010). 
• Lack of access to diagnostics especially near-patient diagnostics and lack of 
treatment guidelines forces physicians to choose empirical antibiotic therapy 
based on experience (Hulscher et al. 2010).  
• The marketing pressures of the pharmaceutical industry and other financial 
incentives for prescribing can influence the choice of antibiotics prescribed (or 
any other drug) (Jack 2011).   
• “The fear of failure” of empirical antibiotic therapy is often quoted as a reason, 
which is further fuelled by the pharmaceutical industry through their biased 
presentation of drug information (Hulscher et al. 2010, Kunin et al. 1973). 
• “The newer the better” is another myth in prescribing that increases patient 
costs and resistance (Avorn and Solomon 2000). 
•  “The more the better” is a myth that arises from a mistaken belief that if the 
effective dose of a particular drug is rather small, then a larger dose and 
prolonged treatment should definitely be better. The pharmacokinetics and 
pharmacodynamics of most antibiotics are complex and require extra effort on 
the part of physicians to understand them (Fishman and Polk 2010, Owens and 
Shorr 2009). 
• Shorter patient consultation time and busy practice is associated with greater 
antibiotic prescribing (Gjelstad et al. 2011). 
• There are often limited opportunities for continuing professional development 
for physicians, especially in low and middle-income countries (Adkoli et al. 
2009, Vati and Walia 2001).  
• Empiric spiralism, as explained earlier (Kim and Gallis 1989).  
• Lack of innovation by the pharmaceutical industry in approach to treatment of 
infections in general and development of new antibiotics in particular has 
resulted in an empty pipeline of antibiotics against multi-drug resistant bacteria 
(Boucher et al. 2009). 
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1.5 RATIONALE OF THE STUDIES 
1.5.1 Drug utilisation studies with focus on antibiotic use from India 
In India little is known about antibiotics prescribing for a given clinical diagnosis. Drug 
utilisation studies done in India show that antibiotics are one of the most frequently 
prescribed drug groups (Sivaraman et al. 2009, Patel et al. 2005, Jhaj et al. 2001, 
Dineshkumar et al. 1995, Biswas et al. 2000, Karande et al. 2005), but there are 
surprisingly few published studies of antibiotic prescribing done in India using the WHO 
ATC/DDD methodology (Holloway et al. 2011, Kotwani et al. 2009, Kotwani et al. 2010, 
Sharma and Barman 2010, Wattal et al. 2005). The primary reason for the lack of such 
studies is the fact that in most health care facilities antibiotic use data is not collected at 
all. At pharmacy level there can be sales without prescription thus limiting the accuracy 
of the data. The standardised method of reporting for outpatient antibiotic use suggested 
by the WHO ATC/DDD methodology is DDD per 1000 inhabitants per year. This type of 
reporting is not possible currently as most health-care set-ups in India have no defined 
population to which they cater. Patients often travel to distant hospitals and purchase 
prescribed medications from pharmacies close to where they reside. Lack of a 
computerised tracking system makes DDD per 1000 inhabitants a redundant concept for 
countries like India. In view of the paucity of studies and the methodological challenge 
two surveillance studies were planned adapting the WHO, ATC/DDD methodology to 
suit the local context. One study was planned among outpatients (Paper I) and other 
among admitted patients (Paper II).  
 
1.5.2 Adherence to treatment guidelines for diarrhoea 
WHO and UNICEF, since 2004 recommend that all children with acute diarrhoea be given 
zinc in some form for 10 to 14 days during and after diarrhoea (10 milligrams per day for 
infants younger than 6 months and 20 milligrams per day for those older than 6 months) 
(UNICEF and WHO 2004). The Indian Academy of Paediatrics also has recommendations 
on ORS and zinc use since 2004 (Bhatnagar et al. 2004), which were re-endorsed in 2006 
(Bhatnagar et al. 2007). Later in 2007, the Government of India recommended use of zinc 
for acute diarrhoea. The National Rural Health Mission included ORS and zinc in the list of 
drugs to be made available to the sub centres (Bhatnagar et al. 2010). In spite of this only 
about 34% of the children with diarrhoea are prescribed ORS and only about 1% children 
are prescribed zinc (Gitanjali and Weerasuriya 2011). Improving the case management of 
diarrhoea can be considered as one of the few “low hanging” fruits for reducing child 
mortality, as the two most important interventions, i.e. ORS and zinc use, can be scaled up 
using a massive public health campaign, and with minimal funding (Sabot et al. 2012). 
However, there has been no reported follow up on adherence to treatment guidelines in 
India. So, a study on prescriptions for diarrhoea among children in Ujjain, India, to 
determine factors associated with adherence to treatment guidelines by the prescribing 
physicians was planned (Paper III). 
 
1.5.3 Importance of surveillance of antibiotic resistance among commensal and 
pathogenic bacteria 
There is a serious lack of surveillance initiatives in resource-constrained settings, where the 
burden of infections requiring effective antibiotics is higher (Ashley et al. 2011, WHO 
2005a). In India there is no systematic surveillance of antimicrobial resistance at national or 
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regional level. The National Centre for Disease Control, under the Director General of 
Health Services, Ministry of Health and Family Welfare, Government of India, published 
The National Policy for Containment of Antimicrobial Resistance, India (The National 
Policy for Containment of Antimicrobial Resistance, India  2011). However, the policy 
lacks a solid evidence base from studies done in India. The main constraint for generation 
of evidence-base for policy is lack of laboratory capacity in many parts of India and many 
low and middle-income countries (WHO 2011). In view of the paucity of studies from 
India, two surveillance studies, one on nasal carriage of commensal S. aureus in children 
below five years of age (Paper IV) and the other on bacterial pathogens isolated from the 
patients with suspected infections (Paper V) were planned.  
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2 AIMS AND RESEARCH QUESTIONS 
 
2.1 AIMS 
The main aim of the thesis is to increase the knowledge regarding antibiotic prescribing 
patterns and prevalence of resistance using two hospitals in Ujjain, India as examples. The 
knowledge and methods will be used to identify targets for intervention to improve clinical 
practice with regards to antibiotic prescribing in this and similar settings.  
 
 
2.2 RESEARCH QUESTIONS 
 
Diagnosis prescribing 
• What is the pattern of prescribing for common infections in outpatient clinics of 
the two hospitals? 
• What is the pattern of prescribing for common infections in admitted patients of 
the two hospitals? 
 
Adherence to prescribing guidelines 
• What is the adherence to treatment guidelines by health-care providers in city of 
Ujjain for diarrhoea in children? 
 
Resistant bacteria 
• What is the prevalence of nasal carriage of S. aureus in healthy children below 
five years and what is the antibiotic sensitivity of S. aureus isolates? 
• What is the prevalence of, and antibiotic sensitivity of, pathogenic bacteria among 
patients with suspected infections in the two hospitals? 
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3 PATIENTS AND METHODS 
3.1 STUDY DESIGN 
All the five studies of the thesis were cross-sectional using quantitative methods. The first 
two studies were conducted to understand the prescribing pattern for common infections or 
infectious disease complaints in outpatient clinics (Paper I) and the prescribing patterns for 
common infections using “foci of infection” approach among admitted patients (Paper II) 
in the two hospitals in Ujjain, India. Another of the studies (Paper III) was performed to 
estimate the adherence to treatment guidelines for acute diarrhoea, a common infection 
among children. Paper IV and V were microbiological studies. The study in Paper IV was 
performed to estimate the prevalence of nasal carriage of S. aureus, its resistance pattern 
and factors associated with nasal carriage in children below five years of age. The Paper V 
was done to define the magnitude of resistance among pathogenic bacteria isolated from 
patients with suspected infections. For papers I, II, IV and V the data was collected 
repeatedly over 15 months, from November 2007 to February 2009. Data was first 
collected at the teaching hospital (CRGH) and then at the non-teaching hospital (UCTH), 
for 45 days in each hospital. To allow time for appropriate data management a period of 
15 days was introduced between the two hospitals and the two seasons. Data was thus 
collected four times for 45 days each in the two hospitals. For paper III data was 
collected from 1st June to 14th August 2009.  
 
 
 
 
Figure 3.1: Overview of research questions and overall research framework for the 
thesis. 
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3.2 STUDY SETTINGS 
 
3.2.1 Ujjain and the study settings 
Ujjain district is situated in the western part of state of Madhya Pradesh, India. This region 
is popularly known as Malwa, with agriculture as the main source of income. The district 
has an area of 6,091 sq. km. with a population of about 1.98 million. Ujjain city is the 
administrative centre of Ujjain District with a population of about 700,000 inhabitants  
(Census of India 2011). 
 
Health care infrastructure in Ujjain  
The district chief medical and health officer controls the public health care in Ujjain 
district. There is one district hospital located in Ujjain city. There are two community 
health centres, one in a rural area and one in an urban area. A network of 20 primary 
health centres and 175 sub-centres caters to the rural population. In urban areas, there are 
five civil dispensaries serving the same purpose as primary health centres in rural areas. 
There are four hospitals, one Ayurvedic medical college hospital and four post-partum 
centres in Ujjain district (Deshpande et al. 2004). 
 
Apart from the above public health infrastructure there are five large private hospitals 
(having at least 100 beds), including one teaching hospital attached to Ruxmaniben 
Deepchand Gardi Medical College. In Ujjain district, there are around 300 qualified 
doctors working in different health care facilities. Many of the practitioners in 
government hospitals are allowed to work in private clinics outside of their official hours 
of work. Practitioners from other formal systems of medicine mainly, Ayurveda and 
Homeopathy (around 110 in number) and informal health-care providers (around 800 in 
number) outnumber the allopathic practitioners. Most (82%) of the informal health-care 
providers are based in the rural areas (De Costa et al. 2009, Deshpande et al. 2004). The 
health-care workers trained in AYUSH are not allowed to prescribe allopathic medicines 
but many of them do so. 
 
Private Pharmacies in Ujjain District  
Since most of the health care in India is sought in private health care facilities, it is 
expected that most drugs are dispensed by the private pharmacies. Private pharmacies are 
privately owned pharmacies that sell the drugs for profit. In a mapping study using the 
geographic information system a total of 475 private pharmacies were identified in the 
Ujjain district (Sabde et al. 2011). Three-quarter of the pharmacies were in urban areas, 
concentrated around physician practices. In rural areas, private pharmacies were located 
along the main roads. It was found that medicines were sold to 39% of the clients without 
prescription. The mapping study also showed that only 11.5% of the pharmacy staff had 
any formal pharmacist qualification (Sabde et al. 2011).  
 
The specific study hospitals 
The specific settings of the studies were two hospitals (Paper I, II, IV and V), namely the 
V.D. Gardi Charitable Trust Hospital (UCTH or non-teaching hospital) and the 
Chandrikaben Rashmikant Gardi Hospital (CRGH or teaching hospital). The non-teaching 
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hospital is a 350 bedded hospital located in the city of Ujjain while the 570 bedded, 
teaching hospital is located about six km from Ujjain city in a village called Surasa. Both 
the hospitals are run and managed by Ujjain Charitable Trust Hospital and Research 
Centre, a non-profit organisation. In both the hospitals qualified allopathic doctors provide 
services. In the non-teaching hospital health care workers provide paid services but the 
hospital is run on a break-even basis. The consultants in the non-teaching hospital are 
allowed to work in private clinics outside of their working hours. The teaching hospital is 
completely charitable and there is no charge for services. Academic professionals manage 
the healthcare services in the teaching hospital. The consultants in this hospital have an 
institutional hospital-based practice and are not allowed to work in private practice. Both 
hospitals cater predominantly to a rural population from the villages surrounding Ujjain 
city. In both hospitals, most admissions (91%) in medical and intensive care units are 
emergency admissions, whereas in the surgical units, both elective and emergency 
admissions are equally common. Treatment guidelines for infectious diseases have not 
been implemented in either hospital. 
 
The above two hospitals in Ujjain were selected as primary sites for all studies (Paper I, II, 
IV and V) as most people seek health care in similar private settings because of the 
inadequacies of the primary public health care in India as discussed earlier. I work in both 
of the above hospitals.  
 
In paper III the settings were five large (more than 100 bedded) hospitals and 17 large 
(based on sales) pharmacies in the city of Ujjain.  
  
 
3.3 SAMPLING AND DATA COLLECTION METHODS 
3.3.1 Pilot studies  
Since these were the first studies undertaken in the area, we had very little or no 
information on the basic data required for sample size calculations. Pilot studies were 
carried out to calculate the sample size, test the data collection instruments, and to train the 
consultants (Paper I, II and V), the resident medical officers (Paper II and III), and the 
study assistants (Paper III and IV). The pilot studies were done in both the teaching and the 
non-teaching hospital. The time and the duration of the pilot studies varied for each study. 
A pilot study was done for one month in March 2007 among outpatients in two hospitals 
(Paper I and IV), on 100 patients each in two hospitals in March and May 2007 among 
admitted patients (Paper II and V) and for two weeks in May 2009 among 25 children with 
diarrhoea (Paper III).  
 
3.3.2 Sample size 
 Sample size calculations were made using the data from the pilot studies (Paper I, II and 
III). For studies in paper IV and V we decided to include all patients detected to be culture 
positive.  
 
The primary outcome in Papers I and II was antibiotic prescribing rate. The antibiotic 
prescribing rate was 60 to 80% for Paper I and 80 to 90% for Paper II in the respective pilot 
studies. For sample size calculation the lower limit of antibiotic prescribing rate was used 
to get the maximum sample size. Thus, using the antibiotic prescribing rate of 60% in 
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Paper I and 80% in Paper II and requesting 80% power to detect a difference of 10 
percentage points for single comparison (the two hospitals in Paper I and “foci of infection 
or antibiotic prophylaxis” in Paper II) in a statistical test for comparison of two proportions 
at 5% significance level, the sample size was 376 for each comparison in study I and 108 
for each comparison in study II. Since, we had 15 foci of infection to be compared the 
minimum sample size was 15×108×2 = 3240 patients in study in Paper II. 
 
For Paper III the primary outcome for sample size calculation was prescribing rate for 
oral rehydration solution (ORS). The estimated rate of ORS prescribing was 50%, which 
was assumed as the basic percentage of prescribing of ORS. Thus, requesting a 95% 
confidence interval for the proportion (0.5) with width no higher than 15%, the minimum 
sample size needed was 170. A design effect of “4” was used to adjust for clustering of 
the data from healthcare facility and the prescribers. The estimated figure of “4” is 
considered a reasonable estimate of design effect in such studies (Rowe et al. 2002). 
Thus, considering the design effect of “4”, gave a minimum sample size of 170×4= 680 
cases with diarrhoea. 
 
3.3.3 Study Participants 
3.3.3.1 Paper 1 
Consecutive patients suspected to have an infectious aetiology (children from the age of 1 
month to 5 years and adults 18 years and above) seen by specialist consultants from 
Departments of Paediatrics, Medicine, Chest medicine, Emergency care, Obstetrics and 
Gynaecology and Surgery (in teaching hospital only) participated in the study. The 
consultant of the concerned specialty suspected the infectious aetiology and made the 
final diagnosis. No external validation of the diagnosis was done. The study was 
undertaken during the outpatient clinics between 9:00 AM and 4:00 PM on weekdays, 
except Sundays and public holidays. A total of 62 consultants out of the available 70 
participated voluntarily in the data collection, which covered 80% of the first 
consultations for infectious disease complaints. The remaining consultations were done 
outside of the routine working hours, on holidays and were not covered for logistic 
reasons.  
 
3.3.3.2 Paper II 
All patients for whom the admitting consultant suspected an infectious aetiology at the time 
of admission or during the hospital stay and were started on antibiotic therapy, or who were 
given antibiotic prophylaxis were included in the study. Patients admitted for infectious 
aetiologies, requiring anti-infective agents other then antibiotics, and patients diagnosed 
and treated for tuberculosis, were not included. Ninety-six percent of the available 
physicians (n=72) from the neonatal intensive care unit; general medicine, including the 
medicine intensive care unit; general surgery; obstetrics and gynaecology; ear, nose, and 
throat; and orthopaedics of the two hospitals participated voluntarily in the study. 
 
3.3.3.3 Paper III 
Children (aged one month to 12 years) with prescriptions for current episode of diarrhoea, 
who were either a) admitted for acute diarrhoea in one of the five participating hospitals in 
Ujjain city or b) the prescription for acute diarrhoea was honoured in one of the seventeen 
participating pharmacies in Ujjain city. A paediatrician, a qualified medical professional 
(including the AYUSH practitioners) or the informal health care providers could have 
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written the prescription included in the study. The study included prescriptions from 86% 
of the practising paediatricians (n=34) in the city of Ujjain at the time of the study. In the 
participating hospitals the resident medical officers collected data and in the pharmacies the 
pharmacy assistants collected data.  
 
3.3.3.4 Paper IV 
The children aged from 1 month to 59 months visiting the paediatric outpatient clinics of 
the two hospitals for routine immunisation were screened for their health status by a 
paediatrician. Healthy children were recruited in the study to identify nasal carriage of S. 
aureus and its antibiotic sensitivity. A structured questionnaire was filled to explore 
factors associated with nasal carriage of S. aureus. 
 
3.3.3.5 Paper V 
Patients admitted with suspected infections (Paper II) and for whom the admitting 
consultant sent clinically relevant samples for bacterial culture were included in the study. 
Information from non-duplicate, consecutive, bacterial isolates (except for anaerobic 
bacteria and Mycobacteria) from the clinical samples  (urine, pus or pus swabs, blood or 
broncho-alveolar lavage fluid) was presented in the study. 
 
3.3.4 Data collection procedure (form) 
Data collection was done on pre-designed; pilot-tested structured questionnaires (Paper I-
V). For actual questionnaires see Annexure I-V. The forms contained diagnosis or 
symptoms (Paper I) or codes for “foci of infection” which were based on the anatomical 
system or sub-system (Paper II). Details of current diarrhoeal episode, its duration, 
associated symptoms and signs, and drugs prescribed for treating the child (1 month to 12 
years) was included in data collection form (Paper III). Details of epidemiological factors 
suspected to be associated with nasal carriage of S. aureus in healthy children (1 month to 5 
years) were included (Paper IV). Details of clinical site of infection and the corresponding 
samples sent for bacterial culture from admitted patients with suspected infections were 
included in the structured questionnaires (Paper V).  
 
The form used in Paper I has been adapted from similar studies done in Sweden (Andre et 
al. 2002, Andre et al. 2008, Lundborg et al. 2002). The form used in study II has been 
adapted from point prevalence studies of Strama and the European Surveillance of 
Antibiotic resistance (ESAC) (Ansari et al. 2009, Molstad et al. 2008).  
 
Demographic details of the patients varied according to the study and were tailored from 
the feedback and results of the pilot studies. Details of diagnostics done (Paper I, II, III and 
V) were not included and assessment of severity of illness (Paper I, II and III) was not 
carried out due to non-feasibility of data collection over the long period of time planned for 
the study.  
 
3.3.5 Measuring antibiotic prescribing 
Antibiotic prescribing data (Paper I and II) were collected at individual patient level and 
were grouped according to the suspected infectious aetiology. Each prescribed antibiotic 
was coded according to the World Health Organization (WHO) Collaborating Centre for 
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Drug Statistics Methodology, Anatomical Therapeutic Chemical (ATC) classification with 
Defined Daily Dose (DDD) 2009 (Methodology 2010) as defined in the ATC fifth level in 
J01 (antibacterial for systemic use). Imidazole group (P01AB) and netazoxanide 
(P01AX11) were also included. The DDDs were calculated per 1000 patients per diagnosis 
(DDD/TPD) (Paper I) and the focus-specific DDDs were calculated per hundred patient 
days (DDD/HPD) (Paper II).  
 
3.3.6 Laboratory methods 
3.3.6.1 Antibiotic susceptibility testing  
Swabs from anterior nares were cultured within four hours of receipt in the microbiology 
laboratory on 5% sheep blood agar plates, incubated at 35 ± 1°C and examined for growth 
after 24-48 hours (Paper IV). The clinical samples were plated on blood agar and (or) 
MacConkey’s agar medium (HiMedia Laboratories Pvt. Ltd, Mumbai, India) within four 
hours of receipt in the laboratory (Paper V).  
 
The bacteria were identified by their typical colony morphology, results of Gram’s staining 
and conventional microbiological methods (Murray PR 1999).  
 
Antibiotic susceptibility testing (AST) was performed by Kirby-Bauer disk-diffusion 
method on Muller Hinton agar plates. The disk strengths (antibiotic concentrations) were as 
recommended by the Clinical and Laboratory Standards Institute (CLSI) at the time of the 
study (CLSI 2006). CLSI interpretive criteria for susceptibility and resistance were 
followed (CLSI 2006). AST quality control was performed using the following reference 
strains: Escherichia coli ATCC (American Type Culture Collection) 25922, Klebsiella 
pneumoniae ATCC 70063, Pseudomonas aeruginosa ATCC 27853, Enterococcus faecalis 
ATCC 29212 and Stapylococcus aureus ATCC 29213. For Gram-negative bacteria, the 
intermediate susceptible isolates were counted as resistant in calculations. 
 
Extended-spectrum beta lactamase (ESBL) production was detected using the double-disk 
synergy test (Jarlier et al. 1988). Presence of ESBL was assayed using the following 
antibiotic disks: cefotaxime (30 µg), cefotaxime/clavulanic acid (30/10 µg), ceftazidime 
(30 µg) and ceftazidime/clavulanic acid (30/10 µg); (HiMedia Laboratories Pvt. Ltd, 
Mumbai, India). According to the CLSI criteria for ESBL detection, each isolate with an 
inhibition zone diameter of ≤22 mm for ceftazidime or ≤27 mm for cefotaxime was 
considered to be a potential ESBL producer or screen positive. A zone diameter increase of 
≥5 mm for either antimicrobial agent when tested in combination with clavulanic acid 
versus when tested alone was considered as an ESBL-producing organism. K. pneumoniae 
ATCC 700603 (positive control) and E. coli ATCC 25922 (negative control) were used for 
quality control in the ESBL tests (Jarlier et al. 1988).  
 
Inducible clindamycin resistance for S. aureus was detected by double disk-diffusion test 
(D test); performed by placing the clindamycin and erythromycin disks 15 mm apart 
(Fiebelkorn et al. 2003).  
 
Multi-drug resistant (MDR) isolates were defined as those isolates having co-resistance to 
three or more antibiotic groups (Magiorakos et al. 2011). 
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3.4 DATA ANALYSIS 
For all studies data were entered in Epidata software (Version 3.1, Epidata software 
Association, Odense, Denmark) and transferred to Stata version 10 (Stata Corp., College 
Station, TX, USA) for further analysis. The data was double entered and checked. 
 
As presented in Figure 3.1 the five research questions of the thesis were investigated in five 
papers. The outcome in paper I was antibiotic prescribing calculated as DDD per TPD 
among patients with suspected infections attending outpatient clinics. Antibiotic 
prescribing among admitted patients calculated, as DDD per HPD was the outcome in 
paper II. The primary outcome in paper III was ORS prescribing rtae. The secondary 
outcomes were (a) prescribing of “ORS together with zinc” and (b) “antibiotics”. For paper 
IV the outcome was prevalence of nasal carriage of S. aureus in children below five years 
of age and prevalence of antibiotic resistance among isolates of S. aureus. For paper V the 
outcome was prevalence of antibiotic resistance among pathogens cultured from admitted 
patients with suspected patients.  
 
Descriptive statistics were presented as mean, median and (or) proportion (Paper I to V). 
Two-by-two tables were made to calculate crude odds ratio (OR) using Chi square test. The  
P-value smaller than 0.05 were taken to define statistical significance. The test of 
significance was two-sided. Odds ratios and their 95% confidence intervals (CI) were 
also computed (Paper I, III, IV and V).  
 
Logistic regression models were fitted for studies in papers III and IV to determine the 
factors associated with the outcome (as defined above). In paper IV a given variable was 
entered in the final multivariate logistic model if the bivariate analysis yielded a P value 
less than 0.1. All the variables were adjusted for age and sex. A complete case series 
analysis was used. A post-hoc power calculation was done for the study in paper IV and 
was found to be 0.98.  
 
In paper III two multivariate stepwise logistic regression models, one for each secondary 
outcome variable, were computed. The outcome variables were controlled for design 
effect due to intra cluster correlation (ICC). Covariates found significant in bivariate 
analysis using Chi-square test at a level of P < 0.20 were included in the model and 
removed using a backwards stepwise method (Wald test with removal level of 
significance of P < 0.10). Bonferroni correction was applied for OR’s because of the 
double comparison of independent variables with two outcomes. A value of P < 0.05 was 
considered statistically significant in the final models.  
 
3.5 ETHICAL CONSIDERATIONS  
The ethics committee of R.D. Gardi Medical College has approved the overall proposal 
(approval number 41/2007). The ethics committee considered the Indian Council of 
Medical Research (ICMR) guidelines (icmr.nic.in/ethical_guidelines) before clearing the 
project. After explaining the purpose of the study informed consent of all participants was 
sought in local language (Hindi). The consent was obtained orally for studies presented in 
Papers 1 and III, while written informed consent was taken for studies presented in Papers 
II, IV and V. There was no change in the care offered to the patients who refused to 
participate in the study, however the refusal rates were very low (1.3% overall). All 
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information revealing personal identity has been kept confidential. The participating 
consultants were informed about culture results of each patient they were in charge of 
(Paper IV and V). The children that were found to be culture positive for S. aureus were 
counselled and were offered treatment with mupirocin cream for local application for seven 
days. The patients were not charged for cultures obtained during the study period. The 
potential future benefit of the project was explained to the patients, as the empirical 
antibiotic therapy needs to be guided by prevailing sensitivity patterns. 
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3.6 SUMMARY OF METHODS 
Paper I II III IV V 
Research 
questions 
What is the 
pattern of 
prescribing 
for common 
infections in 
outpatient 
clinics of the 
two 
hospitals? 
What is the 
pattern of 
prescribing 
for common 
infections in 
admitted 
patients of the 
two hospitals? 
What is the 
adherence to 
treatment 
guidelines 
for diarrhoea 
in children 
in the city of 
Ujjain? 
 
What is the 
prevalence of 
nasal carriage 
of S. aureus 
in healthy 
children 
below five 
years and 
what is the 
antibiotic 
sensitivity of 
S. aureus 
isolates? 
What is the 
prevalence 
of and 
antibiotic 
sensitivity of 
pathogenic 
bacteria 
among 
patients with 
suspected 
infections in 
the two 
hospitals? 
Study setting Outpatient 
clinics of two 
hospitals, the 
UCTH1 and 
CRGH2 
Admitted 
patients of 
two hospitals, 
the UCTH1 
and CRGH2 
Five large 
hospitals3and 
17 large 
pharmacies4 
in the city of 
Ujjain 
Paediatric 
immunization 
clinics of two 
hospitals, the 
UCTH1 and 
CRGH2 
Admitted 
patients of 
two 
hospitals, 
the UCTH1 
and CRGH2 
Design 
(Quantitative) 
Cross-
sectional with 
repeated data 
collection 5 
Cross-
sectional with 
repeated data 
collection 5 
Cross-
sectional  
Cross-
sectional  
Cross-
sectional  
Study 
population  
5623 
consecutive 
out-patients 
with 
suspected 
infection, 
children 
(aged 1 
month to 5 
years) and 
adults 
6026 
consecutive 
admitted 
patients with 
suspected 
infection, 
children (aged 
1 month to 12 
years) and 
adults 
843 children 
with 
diarrhoea 
(aged 1 
month to 12 
years) 
1562 healthy 
children 
below five 
years of age 
716 
pathogens 
from 2568 
patients with 
suspected 
infections 
(patients in 
paper II) 
Data 
collection 
period 
15 months 
from 
November 
2007 to 
February 
2009 
15 months 
from 
November 
2007 to 
February 
2009 
1st June to 14 
August 2009 
15 months 
from 
November 
2007 to 
February 
2009 
15 months 
from 
November 
2007 to 
February 
2009 
Analysis Descriptive 
statistics 
Descriptive 
statistics 
Logistic 
regression 
Logistic 
regression 
Descriptive 
statistics 
1V.D. Gardi Charitable Trust Hospital (non-teaching hospital), 2 Chandrikaben Rashmikant Gardi Hospital 
(teaching hospital), 3 more than 100-bedded hospitals, 4 based on sales 5 Data were collected for duration of 45 
days each, first in CRGH and then UCTH with a gap of 15 days between hospitals. 
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4 RESULTS AND MAIN LESSONS LEARNT  
Many results of the five studies in this thesis can be considered important targets for 
intervention to improve clinical practice with regards to antibiotic prescribing. I have 
chosen to present the main results and lessons learned from the studies.  
 
4.1 OVERALL ANTIBIOTIC PRESCRIBING 
4.1.1 Paper I 
Antibiotics were prescribed for 3732 patients out of 5623 outpatients with for various 
suspected infections, thus the overall antibiotic prescribing for outpatients was 66.3%. 
Most (98.7%) of the outpatient antibiotics were prescribed as oral formulations. The 
outpatients had a mean of 1.28 antibiotics prescribed. Antibiotic prescribing was less 
frequent by 11.3 percentage units in the teaching hospital compared to the non-teaching 
hospital. Antibiotic prescribing varied slightly with different seasons. Overall antibiotic 
prescribing was highest in summer, with a prescribing rate of 75%, in the outpatient clinics 
of non-teaching hospital but was highest in rainy season in the outpatient clinics of teaching 
hospital with a prescribing rate of 70%. There were differences in antibiotic prescribing 
rates between children and adult patients.  Eighty six percent of the adults in the outpatient 
clinics of non-teaching hospitals and 79% of adults in the outpatient clinics of teaching 
hospital were prescribed antibiotics compared to a prescribing rate of 57% and 40% in the 
non-teaching and the teaching hospital’s outpatient clinics respectively, for children up-to 
the age of 5 years. 
 
4.1.2 Paper II 
Among the 6026 admitted patients 5531 were prescribed antibiotics for one of the fifteen 
“foci of infection”, thus the overall prescribing rate for admitted patients was 92%. Most 
(59%) patients were prescribed one antibiotic. A combination of two, three or four 
antibiotics was prescribed significantly more often in the teaching hospital. HAI was 
identified in 9% of all infections. The most common HAI recorded was skin and soft tissue 
infection due to surgical site infection. The mean length of stay in the teaching hospital was 
7.8 days (95% CI 7.3-8.3 days) and that of non-teaching hospitals 4.2 days (95% CI 4.1-4.4 
days).  
 
4.1.3 Antibiotic prescribing for surgical prophylaxis (Paper II) 
One third of all antibiotic prescribing among the admitted patients was for surgical 
prophylaxis. A total of 1846 patients i.e. 34% of 5531 patients that were prescribed 
antibiotics were given surgical prophylaxis. Among the patients that were given 
prophylaxis (n=1846), 86% (n=1593) received prophylaxis for duration more than one day 
and belonged to the surgical services like departments of general surgery, obstetrics and 
gynaecology, ear, nose and throat and orthopaedics. 
 
4.2 PRESCRIBING FOR ACUTE DIARRHOEA  
Diarrhoea is a common complaint for seeking healthcare in the settings and, in this study, 
also a common reason of antibiotic prescribing. In this thesis there is information on 
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prescribing for 1600 patients presenting with diarrhoea (525 Paper I, 232 Paper II, and 843 
Paper III). Out of these 463 patients (29%) were admitted patients (232 Paper II and 231 
Paper III). The main lessons learnt from the three studies (Paper I, II and III) were: 
a. Comparing antibiotic prescribing for diarrhoea between adults and children in the 
outpatient clinics of the teaching and the non-teaching hospital (Paper I), a higher 
proportion of adults (91%) compared with children (40%, aged 1 month to 5 years) 
were prescribed antibiotics, OR 3.8 (95% CI 2.8 to 5.2, P<0.001). 
b. In the study done in pharmacies and hospitals of Ujjain city 71% of children with 
diarrhoea (aged 1 month-12 years) were prescribed antibiotics (Paper III). 
c. Facility level differences were seen with regards to antibiotic prescribing both in 
outpatient clinics (Paper I and III) and among admitted patients (Paper II and III). 
Antibiotics were prescribed less often in the teaching hospital outpatient clinics, OR 
0.01 (95% CI 0.01-0.04, P<0.001) (Paper III). Also, when the teaching and non-
teaching hospitals were compared directly, the teaching hospital had less antibiotic 
prescribing, OR 0.35 (95% CI 0.22-0.52, P<0.001) (Paper I). 
d. Overall in the two hospitals the nitroimidazole group (metronidazole, tinidazole and 
ornidazole) was the commonest group prescribed (Table 4.2 and Figure 4.1), most 
often in combination with co-trimoxazole (more commonly in the teaching 
hospital) and quinolones (more commonly in the non-teaching hospital) (Paper I).  
e. In the study conducted in Ujjain city the illogical fixed dose combination ofloxacin 
and ornidazole was the most frequent (22% of prescribed antibiotics) oral antibiotic 
prescribed (Paper III). 
f. Practitioners of alternate systems of medicine and informal health-care providers 
(n=171), prescribed antibiotics more often compared to paediatricians (OR 3.21 
95% CI 1.19 to 8.65 P=0.023) (Paper III).   
g. The odds of prescribing antibiotics were significantly higher in the presence of 
fever (OR 3.32, 95% CI 1.82-6.07; P<0.001), stomach pain (OR 7.25, 95% CI 1.81-
28.94; P=0.007) and blood in stools (OR 9.93, 95% CI 3.65-27.01; P<0.001) (Paper 
III). 
h. ORS alone was prescribed in 58% of the prescriptions, while ORS with zinc was 
prescribed in 22% of prescriptions (Paper III). 
i. Practitioners from ‘non-paying’ hospitals are more likely to prescribe ORS and zinc 
(OR 4.94, 95% CI 2.45-9.96, P<0.001) and less likely to prescribe antibiotics (OR 
0.01, 95% CI 0.01-0-04, P<0.001) compared to practitioners from ‘paying’ 
hospitals (Paper III). 
 
 
4.3 ANTIBIOTIC PRESCRIBING FOR PNEUMONIA  
Among outpatients, 422 had presented with symptoms of pneumonia (Paper I) and 611 
patients were admitted with clinical diagnosis of pneumonia (Paper II). The details of 
distribution of number of cases of pneumonia in the two hospitals and two studies are 
shown in the Table 4.1: 
The following lessons were learnt: 
 
a. A total of 4466 DDD/TPD were prescribed for outpatients diagnosed with 
pneumonia (Paper I) and 357 DDD/HPD among admitted patients (Paper II). 
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b. Among adult outpatients with pneumonia the quinolone group (Table 4.2 and 
Figure 4.1) was the most prescribed antibiotic with 1889 DDD/TPD (61% 
levofloxacin, 32% ciprofloxacin). Levofloxacin was prescribed much more often in 
the non-teaching hospital compared to teaching hospital (72% versus 18%) whereas 
ciprofloxacin was prescribed more often in the teaching hospital (Paper I). 
c. Levofloxacin was also the commonest antibiotic prescribed for upper respiratory 
tract infections in the non-teaching hospital (Paper I). 
 
 
Table 4.1 Number of cases of pneumonia in the two hospitals and two studies in Ujjain, 
India   
 
Number of cases of pneumonia Study Hospital 
Adults (%) Children (%) 
Total  
Paper I 
(Outpatient) 
 
Non-teaching hospital 
Teaching hospital 
175 (64) 
68 (46) 
98 (36) 
81 (54) 
(Up-to 5 years of age) 
273 
149 
 
379 
232 
 Paper II 
(Admitted 
patients) 
Non-teaching hospital 
Teaching hospital 
251 (66) 
180 (78) 
128 (34) 
52 (22) 
(Up-to 12 years of 
age) 1033 
 
 
 
d. The tetracycline group (tetracycline and doxycycline) was prescribed more often in 
the teaching hospital both among outpatients (Table 4.2 and Figure 4.1) and 
admitted patients (Paper I and II).  
e. Co-trimoxazole was also prescribed more often in the teaching hospital (Paper I and 
II). 
f. In cases of pneumonia in the teaching hospital tetracyclines (69 DDD/HPD: 63% 
doxycycline and 37% tetracycline) were the most prescribed class, followed by 
quinolones (42 DDD/HPD: 94% ciprofloxacin, 5% levofloxacin), and penicillins 
with extended spectrum (41 DDD/HPD: 76% ampicillin with cloxacillin, 18% 
ampicillin, 6% amoxacillin), and 3rd generation cephalosporins (22 DDD/HPD: 
66% cefotaxime, 24% ceftriaxone) (Paper II).  
g. In the non-teaching hospital 3rd generation cephalosporins (57 DDD/HPD-56% 
ceftriaxone with beta-lactamase inhibitor, 28% ceftriaxone, 12% cefotaxime), 
quinolones (32 DDD/HPD 68% ciprofloxacin, 22% levofloxacin) and co-
amoxyclav were prescribed (Paper II). 
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 Figure 4.1- Relative distribution of defined daily doses per1000 patients per diagnosis (DDD/TPD) of the two hospitals for the diagnosis of 
pneumonia, diarrhoea and urinary tract infection (UTI) (Paper I) 
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Table 4.2 Distribution of defined daily doses of different classes antibiotics per 1000 patients per diagnosis (DDD/TPD) in the two hospitals for 
pneumonia, diarrhoea and urinary tract infection (UTI) in the two hospitals in Ujjain, India (Paper I) 
 
 
Diagnosis Hospital 
Penicillins 
with 
extended 
spectrum 
Penicillins 
with beta 
lactamase 
Tetracyclines 1st generation Cephalosporins 
2nd generation 
Cephalosporins 
3rd gen 
Cephalosporins 
Co-
trimoxazole Macrolides Quinolones 
Imidazole 
group Others 
Pneumonia NTH 177 129 0 30 18 67 32 121 1544 1 2 
 TH 218 24 1453 2 0 15 255 34 434 1 1 
Diarrhoea NTH 0 0 0 1.5 0 41 147 0 828 521 2 
 TH 14 0 11 0 0 6 441 0 284 192 0 
UTI NTH 152 43 295 0.2 0 238 214 8 1051 299 0 
 TH 118 0 2227 0 0 4 100 0 2596 2594 0 
NTH-Non-teaching hospital 
TH- Teaching hospital
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4.4 ANTIBIOTIC PRESCRIBING FOR URINARY TRACT INFECTION AND PYELONEPHRITIS 
The following lessons were learnt from outpatient antibiotic prescribing in urinary tract 
infection (UTI) (Paper I): 
a. In outpatient prescribing study 647 patients of suspected UTI were registered and 
antibiotics were prescribed for 622 (antibiotic prescribing rate 96%). A total of 
9930 DDD/TPD of antibiotics were prescribed for UTI. 
b. The commonest antibiotic group prescribed was quinolones (3647 DDD/TPD). 
Norfloxacin was the commonest antibiotic prescribed in both the hospitals. 
c. Nitroimidazoles (2893 DDD/HPD- 94% metronidazole, 5% tinidazole) were 
prescribed along with quinolones.  
d. Tetracyclines (2522 DDD/HPD-74% doxycycline and 26% tetracycline) were also 
prescribed. 
e. Co-trimoxazole was prescribed to 22 patients (3.4% of the patients). 
f. Third generation cephalosporins (injectable antibiotics) were prescribed to 
outpatients only in the non-teaching hospital. 
The following lessons were learnt from antibiotic prescribing among admitted patients with 
pyelonephritis (n=495) (Paper II): 
a. Both hospitals had a similar pattern of antibiotic prescribing in patients diagnosed 
with pyelonephritis. 
b. Quinolones (commonest antibiotic prescribed-ciprofloxacin) and third generation 
cephalosporins (commonest antibiotic prescribed-ceftriaxone) were the commonest 
groups prescribed in the two hospitals.  
c. Aminoglycosides (commonest antibiotic prescribed-amikacin) were prescribed in 
combination with quinolones or third generation cephalosporins in 50% of cases. 
 
4.5 ANTIBIOTIC PRESCRIBING FOR VAGINAL DISCHARGE AND GENITAL INFECTIONS 
Vaginal discharge as a complaint was responsible for almost half of the total adult female 
outpatient visits in the two hospitals. The following lessons were learnt: 
a. Vaginal discharge was reported in 1361 patients. An overall antibiotic prescribing 
rate of 72.2% was observed.  
b. A total of 21512 DDDs/TPD were prescribed (11632 nitroimidazoles, 9183 
tetracyclines and 434 quinolones). 
c. Metronidazole with doxycycline was the commonest combination prescribed (94% 
of the total DDD/TDP) followed by ciprofloxacin, metronidazole and doxycycline 
combination (3% of the DDD/TPD). The above combination prescribing represents 
“syndromic management” of vaginal discharge. 
d. Macrolides were not frequently prescribed (110 DDD/TPD). 
e. The total duration of therapy was 7 days or less in 73% of the patients. 
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Among the admitted patients with genital infections (n=665; 409 patients admitted in non-
teaching hospital and 256 in the teaching hospital) the following lessons were learnt (Paper 
II):  
a. A total of 272 DDD/HPD were prescribed in the teaching hospital compared to 289 
DDD/HPD prescribed in the non-teaching hospital. 
b. Quinolones (ciprofloxacin or norfloxacin) were more frequently prescribed in the 
teaching hospital compared to the non-teaching hospital, where 3rd generation 
cephalosporins (cefotaxime or ceftriaxone) was the commonest group prescribed. 
c. Co-prescription of antibiotics was common (observed in one third of the patients) in 
both the hospitals. Commonest combination was ciprofloxacin and metronidazole 
in the teaching hospital and cefotaxime with metronidazole in the non-teaching 
hospital. 
d. Aminoglycosides (38 DDD/HPD; 13% of the total DDD/HPD for genital 
infections, in the teaching hospital, and 32 DDD/HPD; 12% of the total DDD/HPD 
for genital infections, in the non-teaching hospital) were also prescribed in 
combination with other antibiotic classes. 
e. Co-trimoxazole was prescribed only in the non-teaching hospital. 
f. Macrolides were not frequently prescribed (less than 3% of total DDD/HPD in both 
the hospitals) 
 
4.6 ANTIBIOTIC PRESCRIBING FOR SKIN AND SOFT TISSUE INFECTIONS  
a. Most of the patients diagnosed as skin and soft tissue infections (SSTI) that were 
seen as outpatients (n=575) were prescribed antibiotics. The prescription rate was 
99.2% for the diagnosis of cutaneous abscess, cellulitis or surgical site infections 
and 85.7% for pyoderma (Paper I). 
b. Among the outpatients co-trimoxazole was the commonest antibiotic prescribed 
(4032.5 DU/TPD) followed by the quinolone group (1873 DDD/TPD-67% 
ciprofloxacin) (Paper I). 
c. Among the admitted patients with SSTI (n=481) also co-trimoxazole was the 
commonest antibiotic prescribed (1361 DU/HPD in the teaching hospital versus 
236 DU/HPD in the non-teaching hospital) (Paper II). 
d. In the teaching hospital aminoglycosides was the 2nd commonest class prescribed 
(58 HPD/HPD), most often in combination with other antibiotic groups. 
e. In the non-teaching hospital 3rd generation cephalosporins (92 DDD/HPD) were 
prescribed most often. Twenty percent of the 3rd generation cephalosporin 
DDD/HPD comprised of ceftazidime with sulbactam/tazobactam. These 
combinations were prescribed most often in patients with hospital associated SSI 
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Figure 4.2-Relative distribution of defined daily doses per 1000 patients per diagnosis 
(DDD/TPD) of the two hospitals for the diagnosis of vaginal discharge (n=1361) and skin 
and soft tissue infection (n=575) (Paper I). 
 
4.7 NASAL CARRIAGE AND ANTIBITOTIC SENSITIVITY OF STAPHYLOCOCCUS AUREUS 
IN HEALTHY CHILDREN BELOW FIVE YEARS (PAPER IV) 
The following are the results of screening of healthy children up-to 5 years of age for nasal 
carriage of S. aureus: 
a. The study included 1,562 children up-to 5 years of age, 902 boys (58%) and 660 
girls (42%). Thirty-nine percent of the children were between 1 and 6 months of 
age, 31% were between 25 and 59 months.  
b. Between 9 to 17% of children in the different age categories utilised anganwadis, 
which are Government of India run mother and child care services (pre-school), 
intended for children between 0 to 6 years of age. 
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c. Antibiotic usage in the last 2 weeks was reported for 26% of children and 8.7% 
had a history of hospitalisation in the last 2 weeks. 
d. The prevalence of nasal carriage of S. aureus was 6.3% (95% CI 5.07- 7.47). Out 
of 98 S. aureus isolates 16.3% (95% CI 8.87-23.77) were MRSA. 
e. The factors significantly associated with nasal carriage of S. aureus were “child 
attending preschool” (OR 4.26, 95% CI 2.25-8.03; P=0.007) or “school” (OR 
3.02, 95% CI 1.27-7.18; P<0.001) and “family size more than 10 members” (OR 
2.76 95% CI 1.06-7.15; P=0.03). 
f. Among the MSSA isolates high proportion of resistance was noted to commonly 
used oral antibiotics: ampicillin (90%), co-amoxiclav (54%), co-trimoxazole (49 
%), ciprofloxacin (23%) and erythromycin (11%). No resistance was noted to 
vancomycin, linezolid or teicoplanin. Higher sensitivity was noted to clindamycin 
(94%), chloramphenicol (87.5%), doxycycline (82.7%), amikacin (81.3%) and 
erythromycin (76.6%).  
g. The MRSA isolates showed resistance to co-trimoxazole (75%), doxycycline 
(44%), ciprofloxacin (44%), levofloxacin (31%) and erythromycin (44%). Among 
the erythromycin resistant strains of MRSA 35% were clindamycin inducible.  h. Out of 82 MSSA isolates four were MDR and out of 16 MRSA isolates three 
isolates (19%) were MDR. Among the seven	   MDR isolates three had received 
antibiotics during the last two weeks.	  	  	  	  	  	  	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3-Antimicrobial susceptibility pattern of 16 isolates of MRSA isolated from 
anterior nares of healthy children below five years in Ujjain, India (Paper IV) 
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4.8 HIGH PREVALENCE OF EXTENDED-SPECTRUM ΒETA-LACTAMASE-PRODUCING 
PATHOGENS (PAPER V) 
a. Out of 2568 patients (median age 25 years (range 0 days to 92 years) admitted with 
suspected infectious aetiology 716 bacterial pathogens were isolated.  
b. Gram-negative infections predominated (62%). The isolated pathogens were 
Escherichia coli (n=149, 21%), Pseudomonas aeruginosa (n=127, 18%) and 
Klebsiella pneumoniae (n=107, 15%) and Staphylococcus aureus (n=221, 31%).  
c. The common diagnoses were: abscesses (56%), urinary tract infection (14%), blood 
stream infections (10%), pneumonia (10%), and vaginal infections (10%). The 
pathogens identified in the abscesses are shown in Table 4.3 and those identified in 
urinary tract infection and blood stream infections are shown in Table 4.4. 
d. Extended-spectrum β-lactamase (ESBL) production in E. coli isolates (n=149) was 
69% (95% CI 61.6–76.6) and in K. pneumoniae isolates (n=107), 41% (95% CI 
31.6–50.5). The antibiotic sensitivity pattern of the common pathogens is shown in 
Table 4.5. The extended-spectrum β-lactamase (ESBL) producing organisms 
showed high percentage of resistance to fluoroquinolones and β-lactams except for 
imipenem and piperacillin-tazobactam. Salmonella typhi remained sensitive to 3rd 
generation cephalosporins.  
e. The methicillin-resistant Staphylococcus aureus (MRSA) constituted 30% of all S. 
aureus isolates and showed resistance to ciprofloxacin (81%), co-trimoxazole 
(76%) and levofloxacin (60%).  
 
Table 4.3 Details of site of infection and proportion of different bacteria (n=393) isolated 
from abscesses in two hospitals in Ujjain, India (Paper V). 
 
Site of infection S. 
aureus 
n=185 
P.    
aeruginosa 
n=84 
K. 
pneumoniae 
n=44 
E. 
coli 
n=43 
 
Others 
n=37 
Skin and soft tissue 
infections (n=141) 118 12 6 2 3 
Surgical site 
infections (n=54) 19 24 3 5 3 
Post traumatic 
wound infections 
(n=38) 
12 11 3 2 10 
Burns (n=61) 12 20 16 7 6 
Empyema (n=19) 8 4 2 3 2 
Otitis media (with 
pus discharge) n=24 8 6 7 1 2 
Breast abscesses 
(n=15) 8 4 2 1 0 
Intra abdominal 
abscesses (n=40) 0 2 5 22 11 
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Table 4.4 Number of the pathogens identified from urinary tract infection (n=103) and 
from blood stream infections (n=75) in two hospitals in Ujjain, India (Paper V)  
 
 
Site of Infection  Number of 
isolates 
UTIa 
  E. coli 
  K. pneumoniae 
  P. aeruginosa 
  Bacillus spp. 
  Others 
  Total 
 
 
61 
25 
6 
3 
8 
103 
BSIb  
   S. typhi  
   CoNS 
   S. aureus 
   P. aeruginosa 
   Others (including 8 isolates of E.coli) 
  Total 
 
21 
20 
10 
6 
18 
75 
 
a UTI: Urinary Tract Infection; most (91%) samples were mid-stream clean catch and the rest urine 
from catheter 
b BSI: Blood Stream infections; samples sent in cases of clinical sepsis  
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Table 4.5 Antibiotic susceptibility pattern of the three most prevalent causes of Gram-
negative infections in a surveillance study in two hospitals, Ujjain, India (PaperV) 
 
Activity by organism (number tested) 
E. coli 
(149) 
P. aeruginosa 
(127) 
K. pneumoniae 
(107) 
Antimicrobial class/agent  
tested 
R (%) R (%) R (%) 
Penicillin 
Ampicillin 
Amoxicillin/clavulanate 
Piperacillin/tazobactum 
 
89 
82 
15 
 
- 
- 
17 
 
97 
90 
21 
Cephalosporins 
Cefuroxime 
Ceftriaxone 
Cefixime 
Cefpodoxime 
Ceftazidime 
 
80 
72 
79 
79 
73 
 
- 
- 
- 
- 
87 
 
93 
79 
96 
75 
82 
Other β  lactum 
Imipenem 
 
2 
 
2 
 
2 
Quinolones 
Nalidixic acid 
Ciprofloxacin 
Norfloxacin 
Ofloxacin 
Gatifloxacin 
Sparfloxacin 
 
92 
83 
85 
80 
79 
80 
 
- 
63 
- 
55 
64 
61 
 
- 
65 
- 
55 
53 
51 
Aminioglycosides 
Gentamicin 
Amikacin 
 
59 
33 
 
69 
38 
 
69 
32 
Others 
Chloramphenicol 
Tetracycline 
Co-trimoxazole 
Nitrofurantoin (tested in 
urine samples only) 
 
33 
92 
83 
12 
 
 
- 
- 
76 
- 
 
- 
- 
94 
- 
                     R, resistant 
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5 DISCUSSION  
 
5.1 OVERALL ANTIBIOTIC PRESCRIBING  
In Paper I an overall antibiotic prescribing rate of 66% was documented in the outpatient 
diagnosis-prescribing study. In a study in Delhi using the exit interview methodology it 
was found that 39% of the patients attending public clinics and 43% of the patients 
attending private health-care facilities were prescribed antibiotics (Kotwani and Holloway 
2011). However, that study was done among all patients attending outpatients and not 
specifically among patients suspected to have an infectious aetiology as in our study. 
Therefore, the proportion of patients receiving antibiotics is not strictly comparable. In 
another study done in secondary level hospitals in Maharashtra in outpatient attendees 
using the WHO core prescribing indicators, 35% of the prescriptions contained an 
antibiotic and 25% of the prescriptions contained an injection (Potharaju and Kabra 2011). 
In our outpatient clinics injectable antibiotics were prescribed to 1.2% of the patients. This 
low rate could be due to the fact that our study involved only antibiotics and not all drugs in 
a prescription. Also, our study was done with only the specialist practitioners and not all 
practitioners. A study done among the Paediatric outpatient clinics of a tertiary care set-up 
found a rate of 29% for antibiotic prescribing among all children attending outpatients 
(Dimri et al. 2009).  
 
In contrast a study done in primary and secondary health-care facilities in Uttar Pradesh, 
India found a high prescribing rate (81.8%) of antibiotics (Kumar et al. 2008). That study 
also noted differences in antibiotic prescribing between health care facilities at different 
levels. Lower prescribing rates were found in government hospitals compared to the private 
hospitals. Practitioners doing speciality practice prescribed fewer antibiotics compared to 
general practitioners. In Paper I facility level differences in the antibiotic prescribing were 
found, with less prescribing (by 11 percent points) in the teaching hospital as compared to 
the non-teaching hospital. This could be due to better opportunities of continuous 
professional development for the teaching hospital staff. Also, it is possible that the 
physicians at the teaching hospitals face less pressure because of a policy of restricting the 
pharmaceutical company representatives. Similar effects of the policy of restricting the 
academic detailing by the pharmaceutical company representatives have been observed in 
European hospitals (Jack 2011). No comparison of antibiotic prescribing between teaching 
and non-teaching hospital have been published from India before. In Europe however, a 
lower prescribing rates in outpatients of teaching hospitals have been observed (Zarb and 
Goossens 2011). 
 
 Higher rates of antibiotic prescribing have been noted in the rural areas compared to the 
urban areas (Kumar et al. 2008). In our study however, the non-teaching hospital located in 
the urban setting had a higher prescribing rate of antibiotics compared to teaching hospital 
located in the rural setting (Paper I). The only earlier published study conducted in the 
province of Madhya Pradesh was done in primary heath centres of Bhopal district and 
found that 63.5% of the prescriptions contained antibiotics (De Costa et al. 2008).    
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Seasonal variations in antibiotic prescribing have not been well studied in India. A study 
conducted in Delhi found very little seasonal variation in antibiotic prescribing, but 
observed slightly higher consumption of fluroquinolones in winter (Kotwani et al. 2009).  
However, seasonal variation in outpatient antibiotic prescribing is well documented in 
studies from Europe (Ganestam et al. 2003, Abell et al. 1999, Adriaenssens et al. 2011). 
These studies show that antibiotic-prescribing peaks occur in Europe during the winter 
season and correlate well with the peaks of influenza season (Ganestam et al. 2003, 
Molstad et al. 2008). This may be due to more frequent diagnostic dilemmas of the 
physicians during the influenza season but nevertheless represents inappropriate antibiotic 
prescribing. The prescribing peaks were also more pronounced in countries with high 
overall rates of antibiotic prescribing (Goossens et al. 2005).  In paper I, higher prescribing 
during summer in the non-teaching hospital and in the rainy season in the teaching hospital 
was observed. In the context of a high overall prescribing rate (66%) these peaks are less 
important, but nonetheless give us important information on the diagnostic uncertainties 
faced by the physicians in the study area. The variation in antibiotic prescribing according 
to seasons deserves to be studied in future studies on outpatient antibiotic prescribing in 
India.      
 
In Paper II, 92% of the admitted patients with suspected bacterial infections were 
prescribed antibiotics. There is no similar published study from India using the WHO 
ATC/DDD methodology and “focus of infection” approach to study antibiotic prescribing. 
ESAC has carried out three point-prevalence surveys on hospital antibiotic use in Europe 
(Zarb and Goossens 2011). These surveys were carried out in the second quarter of the year 
2006 (Ansari et al. 2009), 2008 (Amadeo et al. 2010) and 2009 (Zarb et al. 2011). Higher 
antibiotic prescribing rates among the admitted patients in the teaching hospital compared 
to the non-teaching hospital were observed in our study. This finding is consistent with 
three point-prevalence surveys conducted in Europe (Zarb and Goossens 2011) and one 
study in the United States (Pakyz et al. 2008). The differences in the antibiotic prescribing 
observed between the teaching and the non-teaching hospital can to some extent be 
explained by the differences in the case-mix.  
 
5.2 SURGICAL PROPHYLAXIS AMONG ADMITTED PATIENTS 
In paper II it was observed that about one third of all antibiotic prescribing was for surgical 
prophylaxis. The proportion of patients receiving surgical prophylaxis in our study (34%) 
was higher than that recorded by the ESAC surveys (13 to 15%) (Zarb and Goossens 
2011). The problem of continued prophylaxis for duration of more than 24 hours is an area 
of concern. In our study 86% of the patients receiving surgical prophylaxis received it for 
more than 24 hours, which is inappropriate as most guidelines recommend surgical 
prophylaxis as a single dose sixty minutes before surgery (Dellinger et al. 1994).  Surgical 
prophylaxis of inappropriate duration is also a problem in Europe, where between 53 to 
69% patients received inappropriately long prophylaxis (Zarb and Goossens 2011). Lack of 
stop orders once the surgical prophylaxis is begun or the fears of high infection rate in the 
unit are the main reason cited for long prophylaxis (Zarb and Goossens 2011). So, 
antibiotics are being prescribed to compensate for a poor actual or perceived hygiene 
(environmental or hand hygiene). In a study on perceptions of hand hygiene done in our 
teaching hospital important motivational and infrastructure barriers were identified for 
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introducing hand hygiene practices (Joshi et al. 2012). The duration of surgical prophylaxis 
need to be reduced. Work is ongoing to identify possible methods for this. 
 
5.3  DIARRHOEA 
Pneumonia and diarrhoea are the two most common diseases associated with child deaths 
worldwide (Black et al. 2003). Diarrhoea also contributes to malnutrition, which is the 
commonest underlying cause of child deaths associated with infectious diseases (Black et 
al. 2003). Diarrhoea kills more than 650 children below the age of five years each day in 
India (Gitanjali and Weerasuriya 2011). The WHO launched the diarrhoeal disease control 
programme in 1980s, which included training of the community health workers in 
diarrhoeal case management and promotion of the use of oral rehydration salts (ORS) at the 
community level.  Political and religious leaders, and celebrities endorsed the use of ORS 
in mass media campaigns (Santosham et al. 2010). The result was a steep worldwide fall in 
mortality due to diarrhoea by 75% from 1980s to 2008 (Santosham et al. 2010). Since then 
the mortality rates have remained stable and have not shown a sharp decline of previous 
two decades.  The reduced osmolarity ORS has been shown to reduce stool output by 20%, 
vomiting by 30% and need for unscheduled intravenous fluids by 40% (Santosham et al. 
2010). Zinc therapy has been shown to reduce the duration of acute diarrhoea by 12 hours 
and that of persistent diarrhoea by 16 hours. A child receiving zinc therapy during a 
diarrhoeal episode has a 29% lower relative risk of continuation of acute diarrhoea to the 
seventh day (Santosham et al. 2010). There is one-third reduction in the frequency of 
diarrhoea in the subsequent 2-3 months after a 14-day course of zinc. Community-based 
trials have demonstrated a 51% decrease in overall mortality due to diarrhoea attributable 
to zinc use alone.  
 
In Paper I differences in antibiotic prescribing for diarrhoea between adults and children 
were found. Adults were close to four times more likely to be prescribed antibiotics as 
compared to children. This might be due to differences in training, knowledge and 
perceptions of physicians treating adults compared to paediatricians. The physicians 
treating adults also prescribed more combination therapy compared to paediatricians. The 
commonest combination prescribed for adults was ciprofloxacin with tinidazole. In Paper 
III 71% of the children with diarrhoea seeking care in the participating pharmacies and 
hospitals in Ujjain city were prescribed antibiotics. Illogical fixed dose combination 
therapy was also prescribed to children. One such combination, ofloxacin and ornidazole, 
was the commonest antibiotic prescribed and accounted for 22% of antibiotics prescribed 
to children. These fixed dose combinations are not only pharmacologically illogical, but are 
considered by some experts as unethical prescribing (Chakrabarti 2007). Antibiotic 
prescribing for diarrhoea is not only a waste of financial resources but exposes the patients 
to adverse drug effects and fuels antibiotic resistance by creating the gene pool of resistant 
organisms in the gut (Blake et al. 2003). The most effective policy (if implemented) to 
reduce diarrhoeal morbidity and mortality is promotion of a combination of low osmolarity 
ORS with zinc as an effective treatment without unnecessary antibiotic or drug use 
(Santosham et al. 2010). Unnecessary antibiotic use has been identified as a barrier to 
effective policy implementation to reduce diarrhoeal mortality and morbidity (Santosham 
et al. 2010).  
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The health care providers of alternative systems of medicine and informal health-care 
providers are three times more likely to prescribe antibiotics compared to the paediatricians 
(Paper III). There are insufficient efforts by policy makers to address the issue of awareness 
and knowledge of standard treatment guidelines among health care providers of alternate 
systems of medicine, informal health-care providers and also among the paediatricians. The 
present study demonstrates the need for continuous professional development programmes 
to improve case management of diarrhoea. Unfortunately, improvement of case 
management of diarrhoea is not a priority in many countries including India. Therefore, the 
clinical management of diarrhoea is unlikely to improve by simply introducing oral 
rehydration solution and zinc in treatment guidelines. Dissemination of the standard 
treatment guidelines by community based public health campaign with a renewed political 
will is urgently needed (Santosham et al. 2010).   
 
5.4 PNEUMONIA 
Community acquired pneumonia (CAP) is the third leading cause of all global deaths. 
Among children below five years of age pneumonia is the leading cause of death (Black et 
al. 2010, Wardlaw et al. 2006). It is estimated that 7.6 million children died before the age 
of 5 years in 2010 (Black and El Arifeen 2012). Throughout the world the majority of 
episodes of pneumonia are treated as outpatients (Mandell et al. 2007). In the resource rich 
countries most of the deaths as well as health-care expenditure due to pneumonia occurs in 
hospitalised patients, whereas in the low and middle-income countries most of the deaths 
occur in the community at household level. Lack of availability of health-care facilities and 
(or) effective antibiotics for treatment are equally responsible for mortality in resource-
constrained settings (Mandell et al. 2007). The highest incidence of pneumonia is seen in 
children below 5 years of age and in adults older than 75 years and could be up-to five 
times higher in resource constrained settings as compared to resource-rich countries 
(Ruuskanen et al. 2011). The burden of CAP in the Asia-Pacific is underestimated because 
many episodes are not reported due to: self-treatment, availability of antibiotics over the 
counter, high cost and (or) lack of availability of diagnostics, lack of surveillance 
programmes and empiric antibiotic therapy (Song et al. 2011).  In India Integrated 
Management of Childhood Illness (IMCI) provide guidelines for management of 
respiratory infections, diarrheal diseases, measles, malaria and malnutrition for community 
health care workers (Patwari and Raina 2002). IMCI is a strategy fostering holistic 
approach to child health and development, is built upon successful experiences gained from 
effective child health interventions like immunization, oral rehydration therapy, 
management of acute respiratory infections and improved infant feeding (Patwari and 
Raina 2002). However, a low concordance between physician and IMCI algorithmic 
diagnosis of pneumonia and other severe childhood illnesses has been shown in India (Jain 
et al. 2009).  
 
5.4.1 Aetiology of community acquired pneumonia 
Aetiology of pneumonia varies with age. Bacteria are the most common pathogens. They 
can be “typical” or “atypical” bacteria (Ramirez and Anzueto 2011). The common typical 
bacteria include Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus 
aureus, group A streptococci and Moraxella catarrhalis. The atypical organisms cannot be 
stained by Gram’s stain and cannot be cultured on blood or sputum culture medium. 
  38 
Atypical pathogens include Legionella spp., Mycoplasma pneumoniae and Chlamydophila 
pneumoniae (Ramirez and Anzueto 2011). In severely ill patients and neonates Gram-
negative bacilli, especially Klebsiella pneumoniae and Pseudomonas aeruginosa are 
common. Viruses are also well-recognised pathogens for CAP (Ramirez and Anzueto 
2011). 
 
5.4.2 Treatment of community acquired pneumonia  
It is recommended that empiric therapy should be initiated based on age, most likely 
pathogen, local antimicrobial susceptibility pattern of the pathogens, and the severity of 
disease (Wardlaw et al. 2006, Ruuskanen et al. 2011, Song et al. 2011, Ramirez and 
Anzueto 2011). Early initiation of antibiotics is recommended for reducing mortality 
(Ramirez and Anzueto 2011). For empiric therapy in cases of non-severe pneumonia in 
children (aged less than 5 years) the WHO guidelines recommend oral amoxicillin in the 
dose of 40mg/kg/day, for 3 days in HIV non-endemic areas and for 5 days in HIV endemic 
areas (WHO 2012c). The Infectious Disease Society of America (IDSA) guidelines for 
outpatient treatment in a previously healthy adult with no co-morbidities recommend a 
macrolide (erythromycin, azithormycin or clarithromycin) or doxycycline (Mandell et al. 
2007). A respiratory fluoroquinolone (moxifloxacin, gatifloxacin, levofoxacin or 
gemifloxacin) or a new macrolide (azithromycin or clarithomycin) is recommended in a 
patient with co-morbidities or if the patient has received an antibiotic in the previous three 
months (Mandell et al. 2007). In the admitted patients with pneumonia the empiric therapy 
includes a combination of a beta-lactam antibiotic (to cover typical bacteria) and a 
macrolide (to cover atypical bacteria) or monotherapy with a respiratory fluoroquinolone 
(as they have activity against both typical and atypical bacteria) (Mandell et al. 2007). 
However, in both the hospitals in our study settings at the time of the study standard 
treatment guidelines were not developed. The situation is the same for most of the health-
care settings in the country. There is therefore a need for national guidelines in India for 
most common diseases, which could be adapted for local use in the secondary and tertiary 
level hospitals. 
 
In outpatients with pneumonia a respiratory quinolone, levofloxacin, was prescribed in 
adults diagnosed with pneumonia, more often in the non-teaching hospital than in the 
teaching hospital (Paper I). However, levofloxacin was also the commonest antibiotic 
prescribed for self-limiting upper respiratory tract infection (in the same hospital). This is a 
reason for concern and has been identified as an area for intervention aimed to 
improvement of outpatient antibiotic prescribing. Doxycycline was prescribed in the adults 
diagnosed with pneumonia more often in the teaching hospital. Co-trimoxazole was 
prescribed most often in children with pneumonia in the teaching hospital. However, recent 
evidence does not support the use of co-trimoxazole due to a high rate of treatment failure 
in children with pneumonia (Mandell et al. 2007).  
 
Among the admitted patients (Paper II) both in the teaching and the non-teaching hospital 
most patients were prescribed antibiotics in accordance with the IDSA guidelines. 
Doxycycline was prescribed most often in the teaching hospital and third-generation 
cephalosporins in the non-teaching hospital. Again, like in the outpatient study respiratory 
quinolones were prescribed more often in the non-teaching hospital. 
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5.5 URINARY TRACT INFECTIONS AND PYELONEPHRITIS  
Urinary tract infection (UTI) is a pathogenic invasion of the urothelium with resultant 
inflammation, encompassing a spectrum of upper and lower urinary tract disease 
(Dielubanza and Schaeffer 2011). UTI is the most common extraintestinal infectious 
disease in women, with 50% of all women experiencing at least one episode in their 
lifetime in the United States (Foxman 2002). Most of the UTI are uncomplicated cystitis 
caused by E. coli (86%), Staphyloccocus saprophyticus (4%), Klebsiella sp. (3%), Proteus 
sp. (3%) and others including the Enterobacter, Citrobacter and Enterococcus species 
(Colgan and Williams 2011). The estimated costs of health care visits for UTI in the US are 
$ 1.6 billon per year (Foxman 2002).  
 
By definition an acute uncomplicated cystitis normally means a UTI in a premenopausal, 
non-pregnant woman with no known urologic abnormalities (like stones, stents, catheters, 
neurogenic bladder or polycystic kidney disease) or co-morbidities (like diabetes mellitus). 
In contrast UTI in men are usually complicated (Dielubanza and Schaeffer 2011, Colgan 
and Williams 2011). 
 
The diagnosis of UTI is usually made clinically based on history (Dielubanza and Schaeffer 
2011). Classic symptoms are dysuria, frequency and urgency. Sometimes hematuria or 
supra-pubic discomfort can occur (Dielubanza and Schaeffer 2011, Colgan and Williams 
2011). IDSA updated the guidelines for management of UTI in 2010 (Gupta et al. 2011). 
According to the guidelines no single antibiotic is considered best for treating 
uncomplicated UTI and the choice should be individualised. First line antibiotics suggested 
are: fosfomycin 3 gm single dose, nitrofurantoin for five days, or co-trimoxazole for three 
days. Second line antibiotics are: ciprofloxacin or extended-release ciprofloxacin, 
levofloxacin or ofloxacin (all for three days). Third line includes amoxicillin/clavulanate (7 
days), cefdinir (10 days) or cefpodoxime (7 days). Beta-lactam antibiotics are not 
recommended as first-line therapy for acute uncomplicated cystitis if E. coli resistance in 
the area is above 20% (Gupta et al. 2011).  
 
 Most outpatients (more than 80%) in both hospitals were treated with norfloxacin (Paper 
I). The second commonest choice of antibiotic was inappropriate in both the hospitals, 
which was doxycycline in the teaching hospital and 3rd generation cephalosporins in the 
non-teaching hospital. High use of quinolones and absence of nitrofurantoin prescriptions 
is a cause of concern. Despite the fact that nitrofurantoin was the first oral drug introduced 
in the treatment of UTI more than 50 years ago it retains good activity against E. coli in our 
settings (Paper V) and elsewhere (Kashanian et al. 2008).  
 
Acute pyelonephritis is an infection of the renal parenchyma and the renal pelvis 
(Ramakrishnan and Scheid 2005). It usually results from an ascending bacterial infection. 
Haematogenous acute pyelonephritis usually occurs in an immunosuppressed, chronically 
ill, and debilitated patient. Acute uncomplicated pyelonephritis is caused by typical 
pathogens (E.coli, Stapylococcus saprophyticus, Proteus and Klebsiella sp.) in an 
immunocompetent host with normal urinary tract anatomy and renal function 
(Ramakrishnan and Scheid 2005). E. coli causes more than 80% of the cases of acute 
pyelonephritis (Ramakrishnan and Scheid 2005). Women are five times more likely to be 
hospitalised with this condition but have a better prognosis compared to men 
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(Ramakrishnan and Scheid 2005). The spectrum of clinical presentation varies widely from 
mild presentation to frank sepsis (Ramakrishnan and Scheid 2005).  
 
IDSA guidelines recommend the use of one of the following three initial intravenous 
therapies in adults: (a) a fluoroquinolone, (b) aminoglycoside with or without ampicillin, or 
(c) extended spectrum cephalosporin with or without aminoglycoside (Ramakrishnan and 
Scheid 2005).  The recommended duration of therapy is 7 to 14 days. The antibiotic 
prescribing pattern in two hospitals for patients admitted with pyelonephritis was in 
accordance with IDSA guidelines (Paper II).  Quinolones and 3rd generation cephalosporins 
were the commonest groups prescribed with an aminoglycoside added in 50% of the cases. 
 
5.6 VAGINAL DISCHARGE AND GENITAL INFECTIONS 
There is a very high unmet demand for treatment of obstetric and gynaecological disorders 
in India (Reddy et al. 2011). This demand may be even higher in our study settings due to 
skewed distribution of the health care providers in Ujjain district (Deshpande et al. 2004).  
 
Vaginal discharge can be physiological (normal) or pathological (abnormal in terms of 
quantity, colour or odour) (Spence and Melville 2007). In our outpatient study (Paper I) the 
consultant gynaecologist decided if the vaginal discharge was normal or abnormal. 
Pathological vaginal discharge is usually caused by three conditions: bacterial vaginosis, 
vulvovaginal candidiasis or vaginal trichomoniasis (Spence and Melville 2007). Bacterial 
vaginosis and vulvovaginal candidiasis are thought to be caused by a disturbance of the 
normal vaginal flora and are not sexually transmitted. Chlamydia trachomatis, Neisseria 
gonorrhoeae, and Trichomonas vaginalis are sexually transmitted and can present with 
vaginal discharge but many women are asymptomatic (Spence and Melville 2007). The 
timing, colour, consistency, smell, and presence of itch are important in distinguishing 
between various infections, for example lack of itching makes candidiasis less likely and 
lack of odour makes a diagnosis of bacterial vaginosis less likely (Anderson et al. 2004). 
Inflammation on examination is associated with candidiasis. Pelvic pain, pelvic tenderness, 
and fever should be considered as red flags for pelvic inflammatory disease (Spence and 
Melville 2007, Anderson et al. 2004). However, definitive diagnosis requires microscopy. 
In view of the complexity of diagnostics required for accurate aetiological diagnosis, the 
WHO adopts a syndromic management approach (WHO 2005b). The syndromic 
management is based on identification of a group of symptoms and signs (syndromes) and 
provision of treatment for most organisms responsible for producing the syndrome (WHO 
2005b). Syndromic management was followed in the treatment of vaginal discharge in 
outpatients in both teaching and non-teaching hospitals (Paper I). 
 
In the outpatient prescribing study (Paper I) as shown in Figure 4.2, the most common 
antibiotic prescribed was doxycycline, which reflects syndromic management for 
Chlamydia trachomatis. A high prescribing rate of metronidazole was also documented, 
which reflects syndromic management for bacterial vaginosis and Trichomonas vaginalis. 
Thus, the choice of drugs for syndromic management of vaginal discharge was appropriate 
in the two hospitals. A relatively low prescribing rate for quinolones (norfloxacin) was also 
noted. This might be due to a perceived low prevalence of high-risk patients (and thus N. 
gonorrhoea) in the community. Ideally syndromic management should be adjusted 
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according to local prevalence of infections and their antibiotic sensitivity (Spence and 
Melville 2007). It is important to do such a prevalence study in the settings. 
 
In Paper II the antibiotic prescribing pattern for admitted patients with vaginal infections 
especially the pelvic inflammatory disease were studied. The optimisation of therapy for 
hospitalised genital infections (especially pelvic inflammatory disease) must take into 
account the polymicrobial aetiology of the disease, the severity of the disease, and patient 
compliance with antibiotic use. The optimal treatment for patients admitted with genital 
infections requires an antibiotic with activity against Neisseria gonorrhoeae, Chlamydia 
trachomatis, and Mycoplasma genitalium. Because no single agent covers all of these 
organisms, combination therapy is recommended (Jaiyeoba et al. 2011).  
 
In the teaching hospital, ciprofloxacin or norfloxacin were prescribed, often in combination 
with metronidazole. But ciprofloxacin can be associated with possible relapse as it is less 
effective against bacterial vaginosis-associated microorganisms. Also, quinolone resistance 
among N. gonorrhoeae isolates has been increasing in the Asia-Pacific region (Ashley et al. 
2011). Third generation cephalosporins when added to the regimen increase the clearance 
rates and reduce relapse rates (Jaiyeoba et al. 2011).  Third generation cephalosporins were 
used more often in the non-teaching hospital. However, aminoglycosides were overused 
among the admitted patients. Doxycycline, an effective treatment against the Chlamydia 
trachomatis, was sparsely used; also macrolides were prescribed less often for genital 
infections. 
 
5.7 SKIN AND SOFT TISSUE INFECTIONS 
Skin and soft tissue infections (SSTI) can be difficult to treat (Liu et al. 2011, Esposito et 
al. 2009). Severe SSTI are associated with high mortality and morbidity and substantial 
costs. For outpatient management of cellulitis with purulent discharge or a non-drainable 
abscess empiric therapy for MRSA is recommended (Liu et al. 2011). The choice for 
MRSA therapy includes one of the following: clindamycin, co-trimoxazole, a tetracycline 
(doxycycline or minocycline), or linezolid (Liu et al. 2011). The duration of therapy is 5 to 
10 days and need to be individualised based on clinical response. 
 
The cornerstone of treatment for cutaneous abscess and boils is incision and drainage (Liu 
et al. 2011). For cellulitis the treatment of choice is narrow spectrum penicillins. In our 
outpatient study (Paper I) the penicillin group prescriptions for SSTI were low. The high 
prescribing rate of co-trimoxazole in the same study reflects appropriate prescribing.  This 
is because co-trimoxazole is an antibiotic that is effective against both methicillin sensitive 
Staphylococcus aureus and methicillin resistant Staphylococcus aureus (Liu et al. 2011, 
Esposito et al. 2009).  
 
Among hospitalised patients with SSTI, antibiotic therapy should be initiated only if the 
patient fails to respond to incision and drainage or shows abscess with severe and extensive 
disease, rapidly progressive cellulitis, signs and symptoms of systemic disease, associated 
co-morbidities, immunosuppression, or an abscess in an area difficult to drain (face, neck, 
or hand) (Esposito et al. 2009). Thus, defining the severity of illness is central for deciding 
if antibiotics are needed at all, and the route of administration. Most of the admitted 
patients treated with antibiotics for SSTI in the two hospitals did not fulfill these criteria 
(Paper II). The most common choice of antibiotic among admitted patients was also co-
trimoxazole, which appears appropriate. However, the relatively common use of 
quinolones and third-generation cephalosporins is not justified.  
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5.8 NASAL CARRIAGE OF S. AUREUS IN HEALTHY CHILDREN BELOW 
FIVE YEARS OF AGE 
In the past decade there has been emergence of community-associated (CA) strains of 
methicillin-resistant Staphylococcus aureus (CA-MRSA) in community members with no 
previous risk factors for acquisition for MRSA (Kluka 2011). The classic risk factors for 
MRSA infections include hospital care, especially admission to intensive care units, 
extremes of age, immunocompromised patients, and antibiotic use in the recent past (Miller 
et al. 2009).  
 
Nasal carriage in healthy children can account for increasing incidence of respiratory tract 
and deep-space neck infections caused by MRSA. This is because the S. aureus that reside 
in anterior nares of hosts serve as reservoirs for both the exogenous spread of the pathogen 
in the community and predispose the host to subsequent infections by endogenous spread 
(Sivaraman et al. 2009). Persistent nasal carriage (carriage for more than 6 months) is a risk 
factor for endogenous S. aureus infection (Kluytmans et al. 1997).  
 
Studies on prevalence of nasal carriage and antibiotic susceptibility pattern of commensal 
S. aureus in Indian children are few (Ramana et al. 2009, Chatterjee et al. 2009) and have 
been done in children aged between 5 to 15 years of age.  But, there is little knowledge 
about epidemiology of S. aureus in children below five years of age. Paper IV is the first 
study from India reporting S. aureus nasal carriage rate in healthy children below 5 years of 
age. The prevalence of S. aureus was 6.3% out of which 16.3% isolates were MRSA.  
 
The prevalence of nasal carriage is age dependent (Kluka 2011, Miller et al. 2009, 
Sivaraman et al. 2009, Bogaert et al. 2004). The prevalence varied across different age 
groups in our study with lower prevalence in the first six months of life although these 
differences were not statistically significant. The change of colonisation prevalence is 
probably because of competition of the same niche (anterior nares) among many bacteria 
including S. pneumoniae, H. influenzae and M. catarrhalis. It has been demonstrated that 
as age increases the nasal carriage of S. aureus increases and that of other bacteria like S. 
pneumoniae, H. influenzae and M. catarrhalis decreases (Bae et al. 2012). In a study 
among children, colonisation with S. pneumoniae was found to be protective for MRSA 
carriage (Lamaro-Cardoso et al. 2009).  
 
In Paper IV the children attending school or preschool-anganwadi (Government of India 
run mother and child care services) or living in large family size with 10 or more members 
were shown to have significantly higher prevalence of carriage of S. aureus. All the above 
factors can be associated with poor hygiene and overcrowding. Poor hygiene and 
overcrowding have been identified as risk factors for carriage of S. aureus in other studies 
also (Chen et al. 2011, Sivaraman et al. 2009). 
 
In our study (Paper IV) two of the four children carrying MDR isolates of methicillin 
susceptible S. aureus and one of the three children carrying MDR MRSA isolates had 
reported history of hospitalisation. Most of these children had received antibiotics in the 
last two weeks. The children carrying MRSA in our study could have acquired it during 
hospitalisation. MRSA is also a hospital-associated pathogen and so the risk of acquiring it 
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is higher in health care workers (Olsen et al. 2012a). High antibiotic prescribing pressure in 
the study area is reflected by the fact that 26% of children enrolled in our study had 
received an antibiotic in the previous two weeks.  
 
The possibility of horizontal transfer of resistant genes from hospitalized patients to 
community members is also reflected in the susceptibility pattern of S. aureus isolates in 
our study. Early in the global epidemic of MRSA there was a clear distinction in 
susceptibility pattern of CA-MRSA and hospital associated MRSA (HA-MRSA). CA-
MRSA isolates were susceptible to most antibiotics and typically highly susceptible to 
clindamycin (Alekshun and Levy 2006). The isolates in our study show high susceptibility 
to clindamycin but have high resistance to co-amoxiclav (Paper IV). This might represent a 
scenario of spread of resistant genes in the community from the hospitals due to poor 
hygiene measures. 
 
 
5.9 HIGH PREVALENCE OF EXTENDED-SPECTRUM β-LACTAMASE 
PRODUCING PATHOGENS 
Surveillance of antibiotic susceptibility is fundamental for an antibiotic stewardship 
programme. Thus, a surveillance system was set-up in the two hospitals in Ujjain with the 
aim to define the magnitude and pattern of resistance in the bacterial pathogens and also to 
provide locally applicable data to guide empiric therapy. This to our knowledge is the first 
surveillance study that has examined the antimicrobial susceptibilities of common 
pathogens from a rural resource-poor setting in central India. Previously reported studies 
have been done mostly in larger metropolitan cities (Subbalaxmi et al. 2010, Varghese et 
al. 2010). The most common pathogens indentified were S. aureus (31%) followed by E. 
coli (21%), P. aeruginosa (18%), K. pneumoniae (15%). Thus, E. coli, P. aeruginosa, K. 
pneumoniae and S. aureus were responsible for 85% of the culture positive infections. The 
clinical diagnosis of abscesses, pneumonia and UTI were responsible for 80% of all the 
culture positive infections. A high rate of ESBL producing E. coli 69% (95% CI 61.6-76.6) 
and K. pneumoniae 41% (95% CI 31.6-50.5) were found. A similar pattern (Table 4.5) of 
bacterial isolates is noted from other resource-constrained countries (Ashley et al. 2011, 
Jean and Hsueh 2011) and India (Subbalaxmi et al. 2010, Varghese et al. 2010).  
 
The resistance pattern for the two Gram-negative bacteria E. coli and K. pneumoniae 
showed that co-resistance for ciprofloxacin and ceftriaxone was 51.2%. This pattern might 
indicate to AmpC and cephalosporinase producing pathogens. Studies have already shown 
plasmid-borne and (or) chromosomally mediated AmpC β-lactamase producing pathogens 
are common in India (Bhattacharya 2011). 
 
The E. coli isolates from UTI retain good sensitivity for nitrofurantoin (88%) but show 
high resistance to co-trimoxazole (83%). This has clinical implications for outpatient 
management of uncomplicated UTI as guidelines suggest using a fluroquinolone, 
nitrofurantoin or fosfomycin, if co-trimoxazole resistance exceeds 20% among E. coli 
isolates (Mehnert-Kay 2005). Fosfomycin has been recently marketed in India but safety 
and efficacy in children less than 12 years is not established. Thus, nitrofurantoin in view 
of its good susceptibility should be the drug of choice for uncomplicated UTI in our 
settings. 
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SENTRY Antimicrobial Surveillance Program in Asia-Pacific also reported S. aureus as 
the commonest organism followed by P. aeruginosa and E. coli. (Bell et al. 2007, 
Biedenbach et al. 2007). The susceptibility rates found in the present study for 
Pseudomonas (13% for ceftazidime and 37% for ciprofloxacin) are similar to other studies 
from India (Bhattacharya 2011, Mayank et al. 2009). 
 
 
5.10 METHODOLOGICAL CONSIDERATIONS 
5.10.1 Main strengths  
The WHO ATC/DDD methodology for quantifying antibiotic use was used. For DDD 
calculations the data of the actual prescribed antibiotic (Paper I) and the administered 
antibiotics (Paper II) was utilised. This type of data is much more informative than the 
pharmacy sales data where the link between the diagnosis and prescribing is mainly lacking 
even in countries with a computerised database. The link between diagnosis and 
prescribing that was established in both Papers I and II is the main strength of this thesis. 
The results produced by this type of methodology can be directly used for identifying areas 
in need for improving quality of antibiotic prescribing and designing context-specific 
interventions. The range of diagnoses and (or) symptoms that were studied in both the 
above papers have not been studied before from India. There is a great need for this type of 
information to design antibiotic-stewardship programmes in India and counties with similar 
health system.  
 
In Paper III the adherence to treatment guidelines by the prescribers for diarrhoea in 
children were evaluated. The guidelines for rationale prescribing have been in place since 
the year 2004, but no formal evaluation of their adherence had been done before. We 
evaluated the adherence of the guidelines not only among the registered health care 
providers but documented the prescribing pattern of informal health care providers for the 
first time in India. Informal health care providers are usually the first point for seeking 
health-care in many rural areas of India, like in Ujjain district, since the qualified providers 
are geographically concentrated in urban areas (Deshpande et al. 2004). Thus, if we want to 
improve case management of diarrhoea we need to understand the prescribing patterns of 
the informal health-care providers.  
 
In Paper IV the nasal carriage of S. aureus in children below five years of age was 
documented. There are widespread concerns of community spread of S. aureus and 
specifically the MRSA infections. An improved understanding of epidemiology and 
resistance mechanisms of community acquired MRSA is required for better designing 
preventive strategies to stop spread of resistance. Our study is the first from India 
documenting the nasal carriage of S. aureus in healthy children up to five years of age. 
 
5.10.2 Attempts to minimise systematic errors  
Pilot testing of questionnaires  
All the questionnaires used for data collection in this thesis (Paper I-V) were pilot tested 
and revised. All the study assistants and the clinicians were trained for filling the 
questionnaires during the pilot studies. The protocols for the procedures of filling the 
questionnaires (Paper I-V), clinical specimen collection (Paper IV to V) and transport to the 
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microbiology laboratory (Paper IV to V) were defined and field-tested during pilot studies. 
The above procedures were carefully supervised during the data collection period to assure 
quality of the data.  
 
Data entry  
Data entry for Papers I and II was done by me. For the remaining papers, I supervised the 
data entry. The data were double entered and crosschecked for all studies. 
 
Laboratory tests 
Trained microbiologists did all the procedures in the laboratory.  In the microbiology 
laboratory standard operating protocols were devised for all laboratory procedures in 
general and particularly for this study (Paper IV and V). The protocols were harmonised 
together with the colleagues from St. John’s Medical College, Bangalore, a premier tertiary 
care medical college of India and also reference laboratory for a number of 
microorganisms. A proportion (10%) of all the samples were sent to Bangalore for re-
checking the antibiotic sensitivity as an external quality assurance of our laboratory. 
Generally there was good (more than 98%) inter-institute co-relation of antibiograms. I did 
the collection of all the nasal swabs in paper IV.   
 
5.10.3 Attempts to minimise biases  
The paper I and II were diagnosis-prescribing surveys involving the physicians of the two 
hospitals, 62 in the Paper I and 72 in Paper II. Observational studies of this kind can 
involve two common biases. “Desirability bias” means that the physicians knowing that 
they are under observation report lower than actual antibiotic prescribing rates. This kind of 
bias is known as the expectancy effect. In our studies (Paper I and II) the data collection 
was repeated using the same questionnaire four times in each hospital (for a period of 45 
days each) with the same physicians, thus possibly reducing the desirability bias in the two 
studies. In Paper III data was collected in the pharmacies and the prescribers were not 
directly observed. A second common bias in such surveys is the “self-selection bias” i.e. 
only the physicians with a high level of motivation self-select themselves to participate, but 
in our studies the participation rate was high, with 85% of all the available consultants 
participating in Paper I and 96% of all the available consultants in Paper II, thus limiting 
the self-selection bias. 
 
5.10.4 Limitations 
The studies have a few limitations. An external or independent assessment of the severity 
of disease was not done in any of the studies. The assessment of severity would have 
increased our workload further; we found it non-sustainable for long runs in our pilot 
studies. But, areas and diseases have been identified for which an assessment of severity of 
diseases will be done in future studies. The data could not be collected simultaneously in 
the two hospitals (Paper I and II) so the seasonal data are not strictly comparable. The 
WHO ATC/DDD methodology was used for presenting the prescribing data. The main 
limitation of the methodology is that the DDD definition does not allow for dose adaptation 
for children, so when used for presenting antibiotic use in children (Paper I and II) it 
underestimates the total antibiotic use. The design of the study in Paper II required high 
motivation of everybody involved in the study. The study design is very resource intensive 
  46 
especially as the study was done over a long time period. The design is more suitable for 
doing short-term (1 to 2 weeks duration) studies as is shown by ESAC point prevalence 
studies (Zarb and Goossens 2011). In Paper II the focus was on the choice of antibiotics in 
the discussion, as this was the main outcome of the study. Other important aspects of 
rational antibiotic prescribing like duration of treatment and appropriateness of choice of 
formulations for example oral therapy versus intravenous and use of syrup or tablets is not 
discussed. In Paper III an unexpectedly high design effect was reported. Because of this 
high design effect association of some of the variables to prescribing might have been 
missed. In Paper IV data on factors associated with nasal carriage of S. aureus was 
collected using a structured questionnaire. Other factors associated with nasal carrriage 
have been identified since the study was planned. The factors that increase risk of nasal 
carriage of S. aureus identified recently include: exposure to pets (Abdel-moein and Samir 
2011), other family members having an infection with S. aureus or having nasal carriage of 
S. aureus (Olsen et al. 2012a). Low vitamin D levels have also been associated with 
increased risk for carriage of S. aureus (Olsen et al. 2012b). Drinking of hot coffee or tea 
has been shown to be protective for nasal carriage of MRSA (Matheson et al. 2011). In 
Paper IV healthy children reporting for immunisation were studied as a proxy for children 
in the community. Ideally a community-based design would have been better to identify 
factors associated with nasal carriage of S. aureus in healthy children. The genetic 
mechanisms of resistance (mecA gene in Paper IV and genetic mechanism of ESBL 
production in Paper V) have not been tested for the studies in the thesis. 
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6 CONCLUSIONS AND IMPLICATIONS 
This thesis provides much needed information on antibiotic prescribing linked to the 
diagnosis of individual patients in an Indian setting. It also provides information on 
antimicrobial resistance among bacteria (both commensal and pathogens) from two 
hospitals in Ujjain, India. I believe that the findings can be useful for planning antibiotic 
stewardship programmes in other similar settings throughout the world. The thesis 
identified several key areas that call for interventions. These are: 
• Outpatient antibiotic prescribing was found to be less frequent in the teaching 
hospital compared to the non-teaching hospital. Broad-spectrum antibiotics were 
prescribed more often in the non-teaching hospital irrespective of diagnosis and age 
group. 
• High antibiotic prescribing rates were observed for self-limiting diseases like 
diarrhoea and upper respiratory tract infection. 
• A high rate of quinolone prescribing in outpatients is a cause of concern and 
treatment guidelines are needed to define such use for common infections. 
• The method for surveillance adapted for the outpatient diagnosis prescribing study 
appears suitable for busy outpatient settings like ours in India and might be tried in 
other low and middle-income countries. 
• The targets identified for interventions in the surveillance study among admitted 
patients were:  higher antibiotic prescribing in a teaching hospital compared with a 
non-teaching hospital, longer than recommended duration of prophylaxis and lack 
of distinction between prophylaxis and therapy among surgical patients, irrational 
antibiotic prescribing in gastroenteritis, overuse of quinolones and lack of use of 
penicillin in pneumonia, overuse of quinolones and lack of use of doxycycline and 
macrolides in genital infections, and overreliance on antibiotics in treating skin and 
soft tissue infections. 
• Even the specialist paediatricians did not adhere to standard treatment guidelines 
for diarrhoea among children. So, developing guidelines alone is not enough. 
Research, advocacy, political commitment and public health campaigns are needed 
for implementing the guidelines along with training of healthcare workforce.  
• Antimicrobial susceptibility testing and surveillance among the healthy individuals 
commensal bacteria also suggests importance of prudent antibiotic prescribing.  
• High rate of antibiotic prescribing among admitted patients, especially of 3rd 
generation cephalosporins and quinolones together with high rates of ESBL 
producing pathogens, shows urgent need to curb antibiotic use when there is no 
indication for it. The therapeutic armament against the ESBL producing Gram-
negative bacteria is very limited. Thus, to preserve the effectiveness of current 
antibiotics we urgently need antibiotic stewardship programmes. The situation is 
like “the lull before the storm”. The time to act is now!    
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7 FUTURE RESEARCH 
 
• In this thesis targets for intervention with regards to improving antibiotic 
prescribing were indentified. An intervention programme focusing on hospital-
associated infections is ongoing in the teaching hospital in Ujjain. Further 
interventions are planned for outpatient and inpatient prescribing based on the 
results of this thesis.  
• An observational surveillance study should attempt to be more granular in 
determining subtle patterns that may leverage policy changes to improve laboratory 
detection methods. For example, since 2006, CLSI recommends E-test or other 
methods to assess vancomycin MICs for MRSA strains to better appreciate the 
gradations of drug susceptibility and resistance even within the "susceptible range." 
Further, molecular methods are needed to confirm and also to substantiate the 
results obtained from disc-diffusion methods. We are in the process of upgrading 
the microbiology laboratory to address the above-mentioned issues. The molecular 
microbiological work is ongoing at St Johns Research Institute, Bangalore, India. 
• Development of context-specific guidelines and treatment algorithms are ongoing. 
These are to be based on local susceptibility data and epidemiological studies. For 
this, efforts to establish community based cohorts for collection of longitudinal data 
on antibiotic use and resistance are ongoing. 
• Association between overcrowding and carriage of resistant bacteria in the normal 
flora is worthy of further studies. 
• The role of near patient diagnostics has not been well studied in resource-limited 
settings. We need translational research in the area to bring down unindicted 
antibiotic prescribing. We are examining the role of near patient diagnostics in 
treatment algorithms for patients with fever.  
• The duration of surgical prophylaxis need to be reduced. Work is ongoing to 
identify possible methods for this. 
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 APPENDICES  
APPENDIX I: QUESTIONNAIRE USED IN STUDY I 
“APRIAM”: Out-patient Antibiotic use 
 
Date:………………  Department: Paediatrics = 1………   Obgyn=2 …..      
Medicine=3……….  
1. Name ……………………………………………….. 2.  O.P.D. No  
3. Age………..         
Please mark the appropriate option for the items below 
4.  Sex:  Male =1………             Female = 2……     
5. Level of education:      
Illiterate = 1……..      Less than higher secondary = 2……..  Higher secondary=3……                                                    
More than higher secondary = 4…….       
   
SYMPTOMS  
6. Fever:  Yes = 1…..     No= 2……   
7. Duration of fever:   1-3 days=1…….  4-7 days=2……..   >7 days=3……… 
 
8. Respiratory Tract Infection:  Upper respiratory tract infection = 1………   
  
     Pneumonia/Lower Respiratory Tract infection =2 
…………..  
9. Cough:  Yes=1……..      No=2…………  
10. Productive: Yes=1……..      No=2…………  
11. Duration of productive cough;   <7 days= 1……… 7-14 days=2……..        
>14=3…………. 
12. Breathlessness:  Yes=1……..      No=2…………    
13. Ear Discharge:   Yes=1……..      No=2…………   
 
14. Pyoderma: Yes=1……..      No=2…………  
 
15. Urinary Tract Infection. Yes=1……..      No=2…………   
 
16a. Vaginal discharge: Yes=1……..      No=2…………. 
17   Prophylaxis for OPD procedures    Yes =1…….             No=2…………  
18. Diarrhoea 
19a. Loose motions: Yes=1……..      No=2…………  19b. Frequency_______/day 
19c Duration _______Days  
  66 
20. Bottle Feeding: Yes=1……..      No=2…………     
21. Blood in stools: Yes=1……..      No=2…………     
22. Other causes of diarrhea suspected (Eg enteric fever ,malaria or worm 
infestation)Yes=1………          No=2…………     
23. Abscess/Wound discharge: Yes=1……..      No=2…………    
24. Osteomyelitis: Yes=1……..      No=2…………    
PREVIOUS HISTORY OF TREATMENT IN LAST 2 WEEKS 
25. Any treatment in the last two weeks Yes=1……..      No=2…………    
    
26. Name of Antibiotic/s and other drugs previously receive  Known= 1……..
 Not Known =2……… 
27a. Name of first Antibiotic received (if known) ............................... 
27b. Duration of Treatment for first antibiotic received.......................days 
28a. Name of first Antibiotic received (if known) ............................... 
28b. Duration of Treatment for first antibiotic received.......................days 
TREATMENT GIVEN  
29. Antibiotic given  Yes=1……..      No=2…………       
30a. Name of  first Antibiotic (generic name)………………………………   
30b.Dose …………………….. 
30c.Duration of treatment in days………….. 
31a. Name of second Antibiotic (generic name)…………………………   
31b.Dose …………………….. 
31c.Duration of treatment in days………….. 
32a. Name of third Antibiotic (generic name)………………………………   
32b.Dose …………………….. 
32c.Duration of treatment in days………….. 
33a. Name of fourth Antibiotic (generic name)……………………    
33b.Dose …………………….. 
33c.Duration of treatment in days………….. 
 
34a. Name of fifth Antibiotic (generic name)………………………    
34b.Dose …………………….. 
34c.Duration of treatment in days………….. 
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APPENDEX II: QUESTIONNAIRE USED IN DIAGNOSIS-PRESCRIBING STUDY AMONG ADMITTED PATIENTS IN PAPER II 
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APPENDIX III: PRESCRIPTION ANALYSIS OF THE TREATMENT OF ACUTE DIARRHOEA 
IN CHILDREN (UP-TO 12 YEARS) IN UJJAIN, INDIA (PAPER III) 
 
 
A Name of patient: ___________________________                                                        
address_____________________________ 
 
urban / rural   ___  
 
Sex: Male=1 / Female=2   ___                         b1 Pharmacy code:__ 
                                                     b2 Hospital code:__          
 
c    Age __ years __ months ___ days 
 
d    Date of prescription: __field1__field2____ 
 
e    Patient currently : 1) Admitted in hospital   2) Out patient ___ 
 
f    Doctor degree    ____  : 1)MD2) DCH 3) MBBS 4)BAMS  
                              5 BHMS 6) RMP7) other____ (mention name) 
 
g    Years in practice  :__ 
 
Diarrhoea History: 
h    Duration of diarrhea: __ days 
i    Blood in stools: Yes=1  No=2__ 
j    Fever: Yes=1  No=2 __ 
k    If  yes duration in days 1)1-3 days    2) 4-7 days     3) > 7 days ____ 
l    Vomiting: yes=1 no=2 ___ 
m    Pain in abdomen: yes =1  no=2 __ 
 
Treatment given: 
n    Antibiotics given: Yes =1   no=2 ___ 
n1    Name of antibiotic __ 
1.    Ornidazole    
2.    Ofloxacin      
3.    Ornidazole+ofloxacin  
4.    Metronidazole  
5.    Metronidazole+ofloxacin  
6.    Satronidazole+ofloxacin  
7.    Metronidazole+nalidixic acid  
8.    Levofloxacin  
9.    Tinidazole+norfloxacin  
10.   Furazolidone  
11.   Netazoxanide  
12.   Netazoxanide+ofloxacin  
13.   Diloxanide furoate+metronidazole  
14    Other______________________________(write name) 
 
o     Zinc supplements: Yes =1   no=2 __ 
  69 
o1    Name of Zinc supplement __ 
1.    Ascazin  
2.    Emzinc  
3.    Zinconia  
4.    Zinsy  
5.    Z&d  
6.    Zincolife   
7    Other____________________________ 
 
 
p     Pre- pro-biotic prescribed: Yes =1   No= 2 __ 
p1     Name of Probiotic: __ 
1.    Econorm sacht. 
2.    Gnorm sacht.     
3.    Bioclin sacht     
4.    Reflora -r sacht  
5.    Reflora z sacht.  
6.    Bifilac sacht.  
7.    Sporolac sacht./tab  
8.    Sporolac plus  sacht/tab  
9.    Lactofol junior tab  
10.   Cynobac tender. Tab  
11.   Biozora sacht./tab  
12.   Enuff xtra sacht./tab   
13.   Gastroline sacht/tab   
14.   Flora sb sacht/tab       
15.   Cyfolac tab                
16.   Cyfolac jr. tab  
17.   Flora bc syr/tab  
18.   Neutrolin b syr/tab  
19.   Rinifol syr/tab  
20.   Other___________________________________________(write name) 
 
q.    Racecadotril: Yes =1   no=2 ___ 
q1    name___   
1.    Zedott sacht/tab  
2.    Racedott sacht/tab  
3.    Reflora kid sacht  
4.    Enuff sacht/tab  
5.    Ad sacht/tab  
6.    Other______________________________________________(write name) 
 
r    O.R.S. : Yes =1   no=2__ 
r1   name____ 
1.  Electral  
2.  Electrobion  
3.  Rebalanz  
4.  Zintral  
5.  Cosalyte  
6.  Ricetral  
7.  Relyte  
8.  Minerva     
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9.  Other____________________________________________(write name) 
 
 
s. Misc.drugs: Yes =1   no=2 ___ 
 
For fever ,pain, vomiting: 
1.    Paracetamol _ 
2.    Ondasetron _ 
3.    Ranitidine _ 
4.    Dicyclomine _ 
5.    Nimesulide _ 
6.    Mefenamic acid _ 
7.    Domperidone _ 
8.   Other____________________________________________(write name) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix IV: Form used for nasal carriage of S. aureus 
 
R.D.Gardi Medical College, Surasa,Ujjain 
 
APRIAM 
For Commensal                   Place: UCTH / CRGH 
         Dept.:_____________ 
 
□ Perianal swab (PS) (1)                    □ Anterior nares (AN) (2)        
 
Name: ______________________       Date: -- / -- / --                                                                                     
Age:   ____yrs   _____months  ____days    OPD No __/____ 
         Lab ID NO.--/----                                        
For children                                                                                          
Gender             M (1) / F (2)   
   Breastfed   Yes (1)  No (0) 
 School □ Yes (1) □ No (0)                      Anganwadi □ Yes (1)  □ No (0) 
 Family size  ≤4 persons (1)               5-10 persons (2)        >10 persons (3) 
Education of parent :  Illiterate (1)        Primary (2)       ≤ higher secondary (3)  
                              more than higher secondary (4) 
Occupation of parent :   Salaried (1)  Self employed (2) 
H/O Antibiotics received in last 2 wks    □ Yes (1)       □ No (0)      □  Not known 
(2) 
H/O Hospitalization in last 2 wks        □Yes (1)        □ No (0) 
H/O Hospital visit in last 2 wks      □Yes (1)        □ No (0) 
 
For adults 
Family size  ≤4 persons (1)              5-10 persons (2)   >10 persons (3) 
Education :  Illiterate (1)  Primary (2)    ≤ higher secondary (3)  
                                more than higher secondary (4) 
Occupation :   Salaried (1)  Self employed (2) 
H/O Antibiotics received in last 2 wks    □ Yes (1)       □ No (0)      □  Not known 
(2) 
H/O Hospitalization in last 2 wks        □Yes (1)        □ No (0) 
H/O Hospital visit in last 2 wks      □Yes (1)        □ No (0) 
 
tkudkjh i=d Lohdkj ukek 
  
eSa ’kiFk iwoZd ;g dFku djrk@djrh gwW fd eSa fcuk fdlh ekufld ,oa vkfFkZd ncko esa ,oa vius 
foosd ls Lo;a dh jkth ethZ ls bl Lo;a lsok dh bl ;kstuk@ifj;kstuk esa ’kkfey gqvk@gqbZ gWWwA bl 
lanHkZ esa eq÷ks bl ;kstuk@ifj;kstuk dh iw.kZ tkudkjh ,oa rjhds dk Kku igys fn;k x;k gS ,oa eq÷ks 
uewus ,d= djus dh dk;Zfof/k Hkh crkbZ x;h gS ftlls eSa larqq"V gwWA ,oa ;g le>rk@le>rh gqWw fd 
;g dk;Z foKku ,oa ekuork ds Qk;ns ds fy, gSA 
eSa le>rk@le>rh gwW fd esjk lg;ksx bl Kku esa Lo;alsoh  dh rjg gS vkSj eSa fdlh Hkh le; fcuk 
dkj.k crk, blls vyx gks ldrk@ldrh gwW tks esjs dkuwu o Hk;’kftr gd dks Hkh cjdjkj j[krh gSA 
                  gLrk{kj o vxwBs dk fu’kku 
                  fo"k;@dkuwuh ekU; izfrfuf?k 
      _____________ 
71
Appendix V: Form used for Pathogen study 
 
R.D.Gardi Medical College, Surasa, Ujjain 
APRIAM 
For Pathogens               Place: UCTH / CRGH 
                            Dept :  
 
Date of collection                                       Lab ID NO.--/---- 
 
□ PUS (1)             □ SPUTUM (2)       □ WOUND SWAB (3)         □ URINE (4)             
□ THROAT SWAB (5)                       □VAGINAL SWAB (7)       □  OTHERS (6)     
 
Name : __________________________        
                                                                                      
Age   ____yrs ______mths____days  IPD NO/OPD No __/____ 
 
Gender             M (1) / F (2)          
Family size  4 persons (1)     5-10persons (2)    >10 persons (3) 
 
For children 
              Weight in kg:  _______ 
               Breast-fed   Yes (1)    No (0) 
               School           Yes (1)    No (0)              Anganwadi    Yes (1)    No (0) 
               Occupation of parent      Salaried (1)                  Self employed (2) 
    Education of parent:  illiterate(1)     Primary(2)      higher secondary 
(3) 
                          more than higher secondary (4)                                                                                   
               H/O Medication since last 2 wks           □ Yes (1)            □ No(0) 
                   H/O Hospitalization since last 2 wks   □ Yes (1)                 □ No(0) 
                H/O Hospital visit since last 2wks.       □ Yes (1)                 □ No(0) 
 
For adults 
               Education:  illiterate(1)     Primary(2)      higher secondary (3) 
                          more than higher secondary (4)                                                                                   
               Occupation:  Salaried (1)        self employed (2) 
              H/O Medication since last 2 wks            □ Yes (1)                 □ No(0) 
              H/O Hospitalization since last 2 wks    □ Yes (1)                 □ No(0) 
              H/O Hospital visit since last 2wks         □ Yes (1)                 □ No(0) 
 
Provisional diagnosis:        
 ___________________________________________________ 
 
tkudkjh i=d Lohdkj ukek 
  
eSa ’kiFk iwoZd ;g dFku djrk@djrh gwW fd eSa fcuk fdlh ekufld ,oa vkfFkZd ncko esa ,oa vius foosd ls Lo;a dh jkth ethZ ls bl 
Lo;a lsok dh bl ;kstuk@ifj;kstuk esa ’kkfey gqvk@gqbZ gWWwA bl lanHkZ esa eq÷ks bl ;kstuk@ifj;kstuk dh iw.kZ tkudkjh ,oa rjhd s dk Kku 
igys fn;k x;k gS ,oa eq÷ks uewus ,d= djus dh dk;Zfof/k Hkh crkbZ x;h gS ftlls eSa larqq"V gwWA ,oa ;g le>rk@le>rh gqWw fd ;g dk;Z 
foKku ,oa ekuork ds Qk;ns ds fy, gSA 
eSa le>rk@le>rh gwW fd esjk lg;ksx bl Kku esa Lo;alsoh  dh rjg gS vkSj eSa fdlh Hkh le; fcuk dkj.k crk, blls vyx gks 
ldrk@ldrh gwW tks esjs dkuwu o Hk;’kftr gd dks Hkh cjdjkj j[krh gSA 
                  gLrk{kj o vxwBs dk fu’kku 
                  fo"k;@dkuwuh ekU; izfrfuf?k 
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